University of Vermont

UVM ScholarWorks
Graduate College Dissertations and Theses

Dissertations and Theses

2008

Frequency of Marijuana Use and Anxious and Fearful Responding
to Bodily Sensations: a Laboratory Test
Marcel Bonn-Miller
University of Vermont

Follow this and additional works at: https://scholarworks.uvm.edu/graddis

Recommended Citation
Bonn-Miller, Marcel, "Frequency of Marijuana Use and Anxious and Fearful Responding to Bodily
Sensations: a Laboratory Test" (2008). Graduate College Dissertations and Theses. 25.
https://scholarworks.uvm.edu/graddis/25

This Dissertation is brought to you for free and open access by the Dissertations and Theses at UVM
ScholarWorks. It has been accepted for inclusion in Graduate College Dissertations and Theses by an authorized
administrator of UVM ScholarWorks. For more information, please contact scholarworks@uvm.edu.

FREQUENCY OF MARIJUANA USE AND ANXIOUS AND FEARFUL RESPONDING
TO BODILY SENSATIONS: A LABORATORY TEST

A Dissertation Presented
by
Marcel Oliver Bonn-Miller
to
The Faculty of the Graduate College
of
The University of Vermont

In Partial Fulfillment of the Requirements
for the Degree of Doctor of Philosophy
Specializing in Psychology

October, 2008

Accepted by the Faculty of the Graduate College, The University of Vermont, in partial
fulfillment of the requirements for the degree of Doctor of Philosophy, specializing in
Clinical Psychology.
Dissertation Examination Committee:
Advisor

Rex Forehand, Ph.D.

%/

Laura Gibson, Ph.D.

Chairperson

Vice President for Research and
Dean of Graduate Studies

Date: March 5, 2008

Abstract
The current investigation examined the relation between frequency of marijuana use (no
history of use, regular low-frequency use, and regular high-frequency use) and anxious
and fearful responding to a biological challenge paradigm. Ninety-six participants (mage =
22.60, SD = 9.01, 45 females) were recruited from the greater Burlington, Vermont
community and matched on gender, alcohol, and tobacco use. Primary results indicated
that frequency of marijuana use was not significantly related to post-challenge panic
attack symptoms, interest in returning for another challenge (behavioral avoidance), or
changes in anxiety focused on bodily sensations, heart rate, or respiration rate (breaths
per minute). Post hoc analyses suggested that, among current users of marijuana, those
who were dependent on marijuana had greater panic attack symptoms post-challenge
than those who abused marijuana. Further analyses indicated that, among current
marijuana users, those who used the drug for coping reasons were significantly more
likely to exhibit greater avoidance post-challenge as well as greater panic attack
symptoms post-challenge than those who primarily used for other motives. Additionally,
greater frequency of marijuana use among current users was related to less avoidance
post-challenge. Findings of the investigation are discussed in relation to clarifying which
factors of marijuana use may play a role in anxious and fearful responding to bodily
sensations.
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Introduction
The primary goal of the present investigation was to examine the effects of
varying degrees of marijuana use in relation to panic-relevant emotional responding to a
biological challenge procedure.
Marijuana: An Overview of Nature and Use Parameters
Marijuana (also referred to as cannabis) is a drug that is derived from the flowers,
stems, leaves and seeds of the hemp plant (Cannabis sativa). This drug can be
consumed via smoking (e.g. hand rolled cigarettes, water pipes, non-water pipes), or
ingestion (e.g. mixed into foods or used in the process of brewing tea). Marijuana shares
some qualities with tobacco in that it is principally comprised of plant material, often is
used via smoking routes (e.g., pipes, joints), and contains a myriad of chemical
compounds. Unlike tobacco, however, the active agents in marijuana are cannabinoids
(unique to the marijuana plant). There are at least 60 different cannabinoids in
marijuana, and, it is striking that the pharmacokinetics of the vast majority of these
compounds are largely unknown, meaning that there is literally no scientific data about
the vast majority of them (Ashton, 2001). The most well-known, and perhaps
(historically) important, cannabinoid is tetrahydrocannabinol (THC). THC is believed to
be the most potent psychoactive agent in the cannabioid plant (Tanda & Goldberg,
2003).
The technology of growing and distributing marijuana has become a full-fledged
and sophisticated industry (Eck & Gersh, 2000; O‟Dea, Murphy, & Balzer, 1997). The
THC content of plants from various sources and strains varies dramatically (O‟Dea et al.,
1997). With a focus on improved plant breeding and improved growing techniques, the
THC content of marijuana has increased dramatically in a very short period of time. As
one illustrative example, THC content from a typical marijuana cigarette (joint) in the
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1960‟s was 10 mg, whereas estimates suggest it currently is around 1 g (or 150 to 200
mg; Ashton, 2001). One potential large-scale consequence of this increased level of
potency is that much of the scientific database on marijuana, beginning to take shape in
the 1970‟s and 1980‟s, is not likely to be necessarily fully generalizable to current
marijuana use and its correlates. Yet, given that marijuana effects are dose dependent
(greater amount or potency yields greater effect; Tanda & Goldberg, 2003), it is of no
small public health concern that greater “doses” of the drug are now more readily
available in the current time period. As one illustrative, albeit hypothetical, example, one
may theorize that due to greater THC potency, there is the possibility that more
individuals, especially those that are “vulnerable” in some respect, may be more apt to
develop severe problems with marijuana now than in the past.
Pharmacokinetics: a brief synopsis. Only since the discovery of a cannabinoid
receptor within the brain in the late 1980‟s have researchers been able to explicate the
exact process by which THC acts on the brain. Currently, there is evidence of three
potential cannabinoid receptors, only one of which is located within the brain (CB1;
Tanda & Goldberg, 2003). When THC is inhaled into the body via marijuana smoking, for
example, it passes into the lungs and from the lungs into the blood stream (Herkenham
et al., 1990). Once in the blood, THC attaches to cannabinoid receptors, such as CB1,
adding to or reducing the naturally occurring endogenous ligands for these receptors
(e.g. anandamide; Devane et al., 1992). This CB1 receptor in the brain has been found
to mediate both neuro-chemical and behavioral properties of these cannabinoids
including such things as physical dependence and tolerance (Tanda & Goldberg, 2003).
It also is noteworthy that THC and other cannabinoids move rapidly into fat and other
tissues, but are only slowly released from these tissues back into the blood system
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(Hunt, Jones, Herning, & Bachman, 1981); eventually, they are cleared from the body
via urine and fecal matter.
Nature of use: intoxication features. In general, marijuana is used to produce a
mild, relatively short period of intoxication (being “high”). More precisely, marijuana can
produce a range of psychosensory experiences including anxiety, relaxation, acute
paranoia, inhibition, perceptual distortions, and so on (Johns, 2001). Periods of
intoxication depend on use patterns, but tend to last for at least a few hours (Chait &
Zacny, 1992; Ohlsson, Lindgren, Wahlen, Agurell, Hollister, & Gillespie, 1980; Schuckit,
1989). Marijuana intoxication also impairs cognitive and psychomotor performance with
complex, demanding tasks (Hall & Solowij, 1998; Solowij, 1998). Research suggests that
there is a dose dependent relationship between marijuana use and psychomotor and
cognitive impairment, with higher doses being associated with more impairment for more
demanding tasks (Ashton, 2001; Hall & Solowij, 1998). Although cognitive impairment for
hours after using marijuana is a well replicated phenomenon in laboratory studies
(Solowij, 1998), there has been debate about the permanent cognitive effects of using
marijuana (Ashton, 2001). Recent work, however, suggests that individuals who have
used marijuana over long periods of time demonstrate impaired performance on a
variety of neuropsychological tests even when not acutely intoxicated (Hall, Solowij, &
Lemon, 1994), specifically, impairment in attention, memory, and processing complex
information. These negative cognitive effects appear to be present months and even
years after successful cessation (Solowij, 1998). It is interesting to note here that one
key interpretative caveat to this work is that it has not yet been empirically demonstrated
whether these individuals have pre-existing cognitive deficits or whether such deficits
developed secondary to marijuana use.

3

Addictive characteristics. Empirical evidence suggests that marijuana effects on
mood and behavior may develop rapidly (i.e., following relatively few exposures). This
type of behavioral pattern is becoming readily apparent for many drugs, including
tobacco (NIDA, 2001) and cocaine (NIDA, 2004). For many individuals who use
marijuana, tolerance to the drug develops, and presumably, contributes to more frequent
or heavier use patterns or dosing with higher-quality (“more pure THC”) forms of the
drug (Hall & Solowij, 1998). Though presumed by some segments of the general public
to be relatively harmless (Ashton, 1999; Lancet, 1995), marijuana actually has cardinal
features of addiction similar to more “hard drugs.” For example, non-human research,
and more recently, a smaller human empirical data base, suggests that marijuana
discontinuation among regular users produces an internally consistent withdrawal
pattern (see Budney, Hughes, Moore, & Vandrey, 2004, for a review). Examples of key
withdrawal symptoms include disrupted sleep, nightmares, nausea, anxiety, tension,
irritability, sweating, and chills (Budney Hughes, Moore, & Novy, 2001; Budney, Moore,
Vandrey, & Hughes, 2003; Budney et al., 2004; Haney, Ward, Comer, Foltin, &
Fischman, 1999). Many of these withdrawal symptoms appear early after drug
discontinuation (Budney et al., 2003), and some may last for weeks beyond the quit day
(e.g., disrupted sleep; Budney et al., 2003, 2004). This withdrawal profile can appear
relatively quickly during the course of addictive use (Budney, Higgins, Radonovich, &
Novy, 2000; Copeland, Swift, Roffman, & Stephens, 2001; Stephens, Roffman, &
Simpson, 1993; Stephens, Babor, Kadden, Miller & the Marijuana Treatment Project
Group, 2002) and may have clinical import in terms of predicting relapse (Budney, Novy,
& Hughes, 1999), although current data are not yet sophisticated enough to yield
conclusions about this matter. Not surprisingly, there also is research to suggest that,
similar to tobacco use, exposure to marijuana earlier in the lifespan appears to be
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related to more severe and clinically significant forms of drug use, including but not
limited to marijuana, in the future (Kandel, 1975).
Classification of marijuana problems. The current diagnostic criteria for
problematic patterns of marijuana use, according to the DSM-IV, include abuse and
dependence (See Table 1 and 2 for diagnostic criteria for marijuana abuse and
marijuana dependence, respectively; American Psychiatric Association (APA), 1994).
Marijuana abuse is a pattern of marijuana use that includes significant and unpleasant
consequences associated with frequent marijuana use. This pattern needs to have
occurred within a 12-month period. Some of the consequences associated with
marijuana abuse include multiple legal problems, repeated use in physically hazardous
situations, and repeated social and interpersonal problems as a result of use. What
differentiates substance abuse from dependence is that abuse only includes harmful
consequences of frequent use, rather than compulsive use, tolerance or withdrawal
(APA, 1994). Although there is evidence to suggest that marijuana withdrawal symptoms
exist (Budney et al., 2004), withdrawal is not currently included in the DSM-IV criteria for
marijuana dependence. It is also important to note that abuse cannot be diagnosed if
marijuana dependence criteria can be met. This important distinction highlights the more
severe nature of marijuana dependence.
Although historically marijuana has been a commonly used drug, there is little
empirical data pertaining to the validity of distinguishing among marijuana use, abuse,
and dependence; that is, the validity and reliability of distinguishing three separate
“types” or “forms” of marijuana use is not well established. Moreover, for a long period of
time, scholars did not uniformly endorse or support a marijuana dependence syndrome
(Budney et al., 2004). Current research has partially laid these earlier questions to rest in
that heavy users of the drug tend to report problems controlling their use, despite noted
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negative consequences, and experience withdrawal and other adverse symptoms when
discontinuing use (see Hall et al., 1994, for a review). In fact, the best estimates suggest
that approximately 1 out of every 10 individuals who use the drug become dependent on
it at some point in the future (Anthony, Warner, & Kessler, 1994), a pattern of data
consistent with alcohol use problems but markedly lower than that found with tobacco
(Anthony et al., 1994).
To date, researchers have employed standardized interviews to index marijuana
diagnoses in a manner identical to those for other types of substances (e.g., alcohol,
tobacco). From this perspective, a DSM-driven classification system can thus be
considered “state of the art.” At the same time, due to the relatively recent emerging
perspective that classification of marijuana along the lines of use, abuse, and
dependence is the optimal and most accurate approach (Budney et al., 2004), it has
been more common historically to denote marijuana use variability by asking
respondents to indicate their level of use (e.g., frequency) over a specified period of time
(Day, Wagener, & Taylor, 1985). From this perspective, having participants specify the
frequency, and perhaps quantity, of marijuana use also can be a most common method
(Chen, Kandel, & Davies, 1997). Collectively, then, deciding upon whether a DSM-driven
classificatory scheme or a more use-oriented assessment protocol is ideal depends on
the specific research question being posed and the theoretical basis for it.
Negative Consequences of Various Types of Marijuana Use: A Selective Overview
There are numerous empirically-established negative consequences of various
forms of marijuana use, ranging from use to dependence or no use to greater amounts
of use. These negative effects are evident in biological, social, interpersonal, and more
recently, psychological realms. I will now highlight negative consequences for which
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research exists in an effort to distill the larger context for understanding the clinical
importance of studying marijuana in relation to psychopathology.
Medical problems. Perhaps the foremost negative effect linked to various types
of marijuana use is its impact on biological processes, particularly the cardiovascular
and pulmonary systems. On the one hand, as would be expected, many of these effects
are similar to those typically found with tobacco. On the other hand, due to the
potentially greater level of carcinogenic properties of marijuana relative to tobacco
(Sridhar et al., 1994), among certain subpopulations of users (e.g., those using
marijuana more frequently), the negative medical effects of this drug are perhaps even
more clinically noteworthy. For example, more frequent marijuana use is associated with
increased risk of severe respiratory illnesses, especially chronic bronchitis (Bloom,
Kaltenborn, Paoletti, Camilli, & Lebowitz, 1987). Other work has shown that when
compared to (1) nonsmokers of either tobacco or marijuana and (2) tobacco smokers
with no marijuana use history, lung function of those who (3) use marijuana but not
tobacco regularly is significantly poorer (Fligiel, Roth, Kleerup, Barsky, Simmons, &
Tashkin, 1997). There has been a series of important large-scale prospective
investigations in this field of inquiry that document the negative effects of marijuana over
time on pulmonary functioning (e.g., Sherrill, Krzyzanowski, Bloom, & Lebowitz, 1991;
Tashkin, 1993; Tashkin, Simmons, Sherrill, & Coulson, 1997). Though the results across
investigations are not fully consistent, they converge on the observation that greater
duration of marijuana use is related to increased bronchitis symptoms (e.g., coughing,
wheezing; Tashkin, 1993). There are also studies of the relations between marijuana
and cancer. Most studies show that there is an increased risk of lung cancer among
more frequent users of the drug (Caplan & Brigham, 1989). Controlled studies of these
cancer-related negative effects of marijuana use, however, are largely underrepresented
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in the literature. In addition to the increased risk for lung cancer, it is noteworthy that
some research suggests that marijuana use may be related to impaired immune system
functioning, but these investigations, again, have not been consistently replicated
(Coates et al., 1990; Hollister, 1992; Kaslow et al., 1989); upon close inspection of these
studies, it becomes clear that some of the inconsistencies of these investigations may be
related to inaccuracies of measurement of marijuana use patterns. A similar set of
issues is evident for linkages between marijuana use and impaired reproductive effects.
Non-human research suggests heavier marijuana use is related to impaired reproduction
capacity (Hall et al., 1994), but controlled evidence among humans is currently lacking.
Social, interpersonal, and lifestyle problems. In addition to the potential risk of a
number of negative physical consequences, adverse social and lifestyle consequences
(e.g. driving while using) related to certain types of marijuana use have been reported.
Here, research is emerging that indicates that certain types of marijuana use have
negative effects on educational attainment and work productivity. Lynskey and Hall
(2000), for example, reviewed evidence suggesting that marijuana use was a
contributing factor to impaired educational attainment, and others have found that
marijuana use leads to reduced workplace productivity (Lehman & Simpson, 1992), as
well as impaired judgment even hours after marijuana use (e.g. among airline pilots;
Leirer, Yesavage, & Morrow, 1991). In all of these studies, a consistent pattern emerges:
the greater the amount of use (measured in frequency of use or severity of use), the
greater the impairment. The mechanisms underlying these use-related effects are as yet
theoretically and empirically unspecified.
Aside from educational and occupational impairment, marijuana use also has
been shown to be related to lifestyle problems. For example, one cross-sectional study
found that those who are dependent on marijuana compared to those who are not
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demonstrate greater levels of clinically significant impairment in life activities (e.g. work
or school performance; Stephens et al., 1993). Additionally, quantity of marijuana use
and acute intoxication have been related to general risk taking behavior and impaired
judgment. For instance, marijuana use has been linked to fatal traffic accidents and
general driving impairment (Everest, Tunbridge, & Widdop, 1989) even after statistically
controlling for the variance accounted for by alcohol use (Gjerde & Kinn, 1991). Other
work suggests that frequent or more severe marijuana use may lead to using more
severe forms of other drugs (e.g., widely publicized, but often controversial, “gateway
theories” of the developmental nature of substance use patterns; Newcombe & Bentler,
1988). One overarching limitation to nearly all work linking certain types of marijuana use
to lifestyle and interpersonal functioning and even future use of other substances is that
there is a dearth of (controlled) prospective evaluations. Thus, conclusions drawn from
extant work should be viewed conservatively and with explicit recognition of the larger
explanatory context of this body of work.
Epidemiology of Various Types of Marijuana Use
With the general background on marijuana use and its disorders provided above,
it is now necessary to briefly describe evidence pertaining to its occurrence in the
population. Here, I have divided the review of the literature into two general sections –
representative and non-representative/community-based samples – for ease of
presentation.
Representative samples. Marijuana is one of the most commonly used
recreational drugs in the world and the most commonly used illicit drug in the United
States (Patton, Coffey, Carlin, Degenhardt, Lynskey, & Hall, 2002, Office of Applied
Studies [SAMHSA], 2004). According to large scale, representative surveys,
approximately 40% (94 million) of Americans above the age of 12 have tried marijuana
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at least once in their lifetime (SAMHSA, 2003). Recent U.S. epidemiologic data also
suggest approximately 25 million people (approximately 8.6%) have used marijuana in
the past year (SAMHSA, 2004); similar findings have been reported outside of the U.S.
(Fergusson & Horwood, 2000; Swift, Hall, & Teesson, 2001). Moreover, over 50,000
adolescents initiate marijuana use on a yearly basis (Office of Applied Studies
[SAMHSA], 2002), and over 35% of current marijuana users (up from 30% ten years
ago) meet criteria for marijuana abuse or dependence (Compton, Grant, Colliver, Glantz,
& Stinson, 2004). In 2002, it was estimated that the prevalence of marijuana abuse in
the past year was 1.1% in the general population, while the prevalence for dependence
was 0.4% (Compton et al, 2004). Though I could not locate estimates of lifetime rates of
marijuana abuse, 4.2% of people in the United States have been diagnosed as
marijuana dependent in their lifetime (Anthony et al., 1994). Empirical reports suggest
that marijuana use is highest among young adults (Ferguson, Horwood, & SwainCampbell, 2002; NIDA, 1997) and may be on the rise among this particular segment of
the population (Ogborne & Smart, 2000; Webb, Ashton, Kelly, & Kamali, 1996).
Non-representative/community samples. Of special relevance to the present
study, many community studies (i.e., investigations that have not used representative
sampling methods for the population as a whole) have examined prevalence rates of
marijuana use among different samples suffering from a variety of medical and
psychological problems. For example, studies have found that among those seeking
treatment for psychosis, approximately 23% currently use marijuana with about half
“misusing” 1 the drug (Green, Young, & Kavanagh, 2005). Another community-based
study found that approximately 16% of those with spinal cord injury used marijuana
(Young, Rintala, Rossi, Hart, & Fuhrer, 1995). Other work suggests that among those
seeking residential drug treatment, marijuana use accounts for as much as 25% of the
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primary drug problems (Didcott, Flaherty, & Muir, 1988). Yet another study has identified
that, among adolescents seeking outpatient services for marijuana abuse or
dependence, approximately 38% report suffering from depression and 29% report acute
levels of anxiety (Diamond, Panichelli-Mindel, Shera, Dennis, Tims, & Ungemack, 2006).
These sources of community data suggest marijuana use (1) may be overrepresented
among certain “vulnerable” populations and (2) is a “serious” drug problem (a primary
clinical concern). Unfortunately, to the best of my knowledge, there is no empirical work
currently available that has addressed the prevalence of marijuana use and its disorders
among treatment-seeking, anxiety-disordered samples.
Collectively, there are a variety of empirical reports that suggest that marijuana
use, abuse, and dependence are among the most common substance use problems in
the world. Moreover, there is emerging evidence that indicates psychiatric populations
may be especially “at risk” for marijuana use and perhaps abuse and dependence
(Isaac, Isaac, & Holloway, 2005). Though the above-reviewed literature does not speak
to the link between marijuana and specific psychiatric disorders, it does raise questions
as to whether marijuana would have higher rates of comorbidity with some disorders and
not others. In an attempt to answer this question, given this background, I now introduce
the constructs of anxiety and panic attacks, and then discuss their relevance to
marijuana use and its disorders.
Anxiety-related Constructs: Conceptual Background and Operational Definitions
The main aim of the present study is to explore whether more frequent marijuana
use is related to anxiety focused on bodily sensations and panic attacks using a
laboratory paradigm. To understand why this research is being studied, an explication of
contemporary conceptualizations of “anxiety” and “panic” are needed. This discussion of
anxiety constructs is especially important to the present study as a central
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methodological shortcoming of the majority of work related to anxiety and marijuana
associations has been poor conceptualization and measurement of anxiety variables.
Scholars have historically debated and intellectually struggled with
conceptualization of emotional states. Not surprisingly, perhaps, there are numerous
theories as to how to best describe emotional states (Izard, 1992; Ekman, 1992; Lang,
1994). These debates about the nature of emotion in general have been especially
apparent in the study of panic attacks and distinguishing such events from other anxiety
states like fear and worry. From the outset, it is important to note that there is no one
“ultimate” definition of emotion; meaning, researchers from various theoretical
backgrounds may operationalize these constructs somewhat differently based upon
varying conceptual frameworks. However, there is nonetheless a growing consensus
that emotional states have numerous “parts” that are systematically coordinated to
respond (often automatically) to specific eliciting cues or stimuli.
For the purposes of the present study, I will build from integrative types of
accounts of emotion, such as the work of Levenson (1994), Ekman (1992), and Fridja
(1988). These theorists posit that emotions are biologically selected reactions that
coordinate adaptive responding to environmental events and challenges (Fridja, 1988).
Thus, specific emotional states like fear, sadness, or anger presumably “coordinate” a
different (specific) set of responses to particular eliciting cues, and by extension, serve a
unique function.2 As emotions presumably serve unique functions, they naturally
experientially possess an imperative quality; that is, they “prioritize” responding and can
disrupt ongoing behavioral responses. Emotions, unlike mood states (prolonged
affective states), tend to occur abruptly, persist for short periods of time, and involve
more marked change across systems (biological, cognitive, and behavioral; Lang, Rice,
& Sternbach, 1972). The abrupt nature of emotional states often means that they can
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operate, especially early in the generative process, beyond conscious awareness (Lang,
1994). At the same time, emotion response tendencies can be modulated to varying
degrees (e.g., enhanced, diminished) – an area of work often referred to as emotion
regulation (Izard, 1990) – and one that may be central to self-regulation models of
substance use and its disorders (Zvolensky, Bernstein, Marshall, & Feldner, 2006).
In contemporary work, “anxiety states” are typically viewed as multidimensional
emotional processes that can be conceptually understood according to a “three channel
response system” (sometimes referred to as a “triple-response mode” or “three-response
mode”) that includes physiological, cognitive, and overt behaviors (Lang, 1994).
Physiological responses associated with anxiety involve a variety of bodily systems, and
lead to such changes as increased heart rate, sweating, muscle tension, and respiration.
Cognitive responses include processes such as thoughts, beliefs, and memories.
Because it is impossible to directly observe thoughts, and often difficult to assess
physiological processes, an individual‟s self-report of these events is frequently
necessary for assessment. Overt anxious behavior most often involves avoidance of
situations and/or objects, or may include prematurely leaving an event (i.e., “escaping”).
It should be noted that channels of “anxiety states” (i.e., physiological, cognitive,
and motor behavior) often are independent of one another (Rachman & Loptaka, 1986).
As an example, a woman who abruptly experiences heart palpitations and feelings of
impending doom associated with panic while in a movie theater may not verbally report a
panic attack. Yet, she may leave the immediate situation (i.e., “escape”), if possible, and
may be more likely to avoid such situations in the future. In this case, anxious
physiological and overt behavioral responses are evident, even though verbal reports of
anxiety are not present. Thus, there is often discordance among these response
channels, and just because a person does not say, “I feel anxious,” at any one time point
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does not necessarily mean that he or she is not having problems with anxiety. In a
similar way, there often is response desynchrony (Rachman & Loptaka, 1986), whereby
the relation between two behavior channels responds to treatment at dissimilar rates
over time. Often, one channel is expected to change first, and the others improve more
slowly, although the exact sequence may vary by type of anxiety and setting events
(Lang, 1994).
There are many qualitatively distinct states that are categorized under the
general label of “anxiety.” Although the scope of the present study does not permit a
detailed description of all such states, it is clear that these negative emotional
experiences overlap considerably. That is, all anxiety states are characterized by the
aforementioned three channels of behavior, yet they differ in regard to core parameters
of response such as duration and magnitude, as well as type of environmental cues
associated with the specific form of anxiety being studied. From this perspective, many
scholars suggest that sophisticated measurement of anxiety states requires (optimally) a
multimethod approach whereby different response channels can be measured and
understood in relation to one another (Lang, 1994). For the purposes of the present
study, I drew on integrative perspectives of anxiety-related states to operationalize my
key emotion constructs. I will now operationalize and discuss the constructs of anxiety,
fear, and panic to provide an organizational basis to the present study.
Anxiety is conceptualized as a primarily cognitive-affective state characterized by
cognitive shifts that focus attention on approaching threat and danger (Craske, 1999). It
is thus best conceptualized as a state of “active mobilization and ongoing vigilance” and
can be contrasted to that of worry, whereby the individual is in a state of “preparation
and readiness.” The future-oriented nature of anxiety for approaching sources of threat
typically means that individuals show less dramatic signs of change in physiological
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systems compared to fearful or panicked states, and greater levels of more elaborate
cognitive-based responses (e.g., “This is a dangerous situation and I need to be vigilant
in case I need to respond;” Lang, 1994). Anxiety also tends to be longer in duration (e.g.,
lasting for hours at times at the extreme) compared to fear or panic states, which last on
the order of 10 minutes or less (Lang, 1994). In this sense, anxiety can be considered
more of a mood state than a specific emotional episode (Lang, 1994).
Though there has been debate about the distinctions between fear and panic
states, most scholars now theorize that these two states are more similar than different
(Craske, 1999). Fear and panic states both involve active fight-flight-freeze responses
and are characterized by a high degree of physiological activation (e.g., heart rate
change), threat-oriented behavioral responses (e.g., escape), and low-level cognition
(e.g., “I need to flee this situation now”). Thus, fear and panic states are oriented
towards imminent threat (cf. approaching or potential threat; Gray & McNaughton, 1996).
Notwithstanding these similarities between fear and panic, one domain in which they
sometimes differ is in regard to the identification of the source of threat (Craske, 1991).
Research suggests that when an individual experiences a fear state as “out of the blue,”
he or she typically refers to this experience as a “panic attack.” In contrast, when a
source threat is identified, the individual is more apt to label the emotional state as “fear”
(see Norton, Cox, & Malan, 1992, for a review).
Here, it is noteworthy to distinguish panic attacks from panic disorder. If one
suffers from a panic attack, one does not necessarily meet diagnostic criteria for panic
disorder. For one to be diagnosed with panic disorder, one must have recurrent
unexpected panic attacks followed by concern about having additional attacks, worry
about the implications of an attack, or change in behavior related to the attacks (APA,
1994). Broadly, a panic attack can be either “cued” (linked to an external stimulus) or
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“uncued” (unable to be cognitively tied to an external stimulus), but must be described as
“uncued” to be considered for panic disorder. From this point forward, I will use the
terms panic and fear interchangeably.
With this background on the nature of emotion and anxiety-related constructs, I
now turn to a discussion of the potential linkages between anxiety-related states and
specific patterns of marijuana use.
Marijuana and Anxiety-related States: Extant Empirical Work
In general, little empirical work has examined the relation between various types
of marijuana use and panic attacks. Indeed, the vast majority of investigations in this
domain have centered on associations between specific types of marijuana use and
depressive symptoms or problems (Chen, Wagner, & Antony, 2002; Degenhardt, Hall, &
Lynskey, 2001, 2003; Green & Ritter, 2000; Kouri, Pope, Yurgelun-Todd, & Gruber,
1995; Patton et al., 2002;). Yet, anxiety and panic attacks have historically been linked –
via clinical observation and case reports – to various types of marijuana use (e.g., Gale
& Guenther, 1971). This work was initially stimulated by the observation that marijuana
use may acutely promote heightened levels of anxiety symptoms and elicit panic attacks
under certain conditions or among certain individuals (Hollister, 1986; Tunving, 1985).
For example, when a person is intoxicated from using marijuana, they may experience
acute paranoia, escalating anxiety symptoms, and perhaps a panic attack. This type of
experience makes intuitive sense in that marijuana can elicit a wide range of sensoryoriented experiences, as described earlier.
At the same time, the acute effects of marijuana on anxiety and fear states may
represent only one possible way in which marijuana and anxiety are linked. Indeed,
drawing from models of anxiety-substance use comorbidity (Zvolensky & Bernstein,
2005; Zvolensky, Schmidt, & Stewart, 2003), there is increasing evidence that more
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regular or severe use of certain substances is related to the future risk of anxiety
problems (Zvolensky, Bernstein, Marshall et al., 2006).3 These models and their
corresponding empirical support highlight the possibility that particular types of
marijuana use may function as a potential risk factor or marker for panic-related
problems. I will now present what is known about this body of knowledge by reviewing
studies that have been completed in this domain. For ease of presentation, I have
divided such work by methodological design and sampling approach. I will conclude this
section with a discussion of the methodological limitations of extant work.
Cross-sectional studies: Community-recruited samples. The vast majority of
studies have explored marijuana use-anxiety associations using cross-sectional designs
and involved samples recruited through the community. In general, these investigations
have utilized assessment devices that are limited in coverage of anxiety processes or
not validated (e.g., Dannon, Lowengrub, Amiaz, Grunhaus, & Kotler, 2004; Tournier,
Sorbara, Gindre, Swendson, & Verdoux, 2003). Additionally, the findings from such work
tend to be mixed and interspersed within a larger a priori focus on depressive symptoms.
Due primarily to their limitations in assessment approaches for anxiety-related states,
and secondary theoretical focus, conclusions drawn from such work regarding panic are
highly suspect and therefore not reviewed in detail. That is, the data from these
investigations are highly questionable because the research designs did not employ
empirically-supported assessment devices that map theoretically onto contemporary
perspectives of anxiety constructs. Of the more recent investigations that utilize
psychometrically sound assessment devices and theoretically-driven approaches, a
number of interesting observations are becoming apparent.
In the earliest study in this domain, Bonn-Miller, Zvolensky, Leen-Feldner,
Feldner, and Yartz (2005) evaluated the incremental validity of regular marijuana use
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and frequency of such use in relation to anxiety and depressive symptoms and
perceived health among young adult tobacco smokers (n = 202). Approximately 72% of
the sample were current marijuana smokers, using this drug an average of 7.6 (SD =
9.2) times per week. As expected, after controlling for theoretically-relevant smoking
(cigarettes per day), alcohol use, affective and cognitive factors (i.e., negative affectivity
and anxiety sensitivity), marijuana use predicted anxiety symptoms and perceived poor
general health, whereas frequency of marijuana use predicted only anxiety symptoms.
These findings suggest a potentially unique association (concurrent) between current
marijuana use (yes/no; between group-effects) and frequency of such use (within-group
effects) as being related to anxiety symptoms and worry about health status.
In a subsequent investigation, Zvolensky, Bonn-Miller, Bernstein, McLeish,
Feldner, and Leen-Feldner (2006) evaluated whether anxiety sensitivity interacted with
marijuana use in relation to the prediction of panic-relevant variables among young adult
tobacco smokers (n = 265). Anxiety sensitivity reflects the fear of anxiety and its possible
negative consequences (McNally, 2002). Approximately 73% of the sample was
composed of current marijuana smokers, with 78.5% of this sub-sample using marijuana
more than once per week. As expected, after covarying cigarettes per day, alcohol use,
and negative affectivity, the interaction between marijuana use and anxiety sensitivity
predicted anxiety symptoms and agoraphobic cognitions. Partially consistent with
prediction, the interaction between frequency of marijuana use and anxiety sensitivity
predicted only anxiety symptoms. There was no main effect for frequency of marijuana
use. These results suggest individual differences in the fear of anxiety may moderate the
association between marijuana use and frequency of such use in relation to panicrelevant variables among regular tobacco smokers.
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Buckner, Leen-Feldner, Zvolensky, and Schmidt (in press) recently replicated
and extended the findings of Zvolensky, Bonn-Miller and colleagues (2006) to
adolescents in the laboratory using a biological provocation paradigm. Here, they
examined whether anxiety sensitivity increased anxious responding (using a threeminute voluntary hyperventilation procedure) among adolescent marijuana users. The
sample consisted of 153 adolescents (46.4% female) between the ages of 11 and 17
(Mage = 14.92, SD = 1.49). Results indicated that anxiety sensitivity moderated the link
between lifetime marijuana use frequency and both post-challenge physiological anxiety
(as indexed by skin conductance) and post-challenge subjective anxiety in female
adolescents (but not male adolescents) such that female adolescents with high anxiety
sensitivity and more frequent marijuana use demonstrated the highest level of challengeinduced fear response. This effect remained even after controlling for relevant variables
(e.g., age, trait anxiety, lifetime alcohol and cigarette use). There was no main effect for
frequency of marijuana use. These data lend some further empirical support to work on
marijuana-anxiety relations.
Collectively, these investigations suggest that, among community-recruited adult
daily tobacco users and adolescents, marijuana use is related to panic-relevant
variables.
Cross-sectional studies: Representative samples. One study examined
marijuana use patterns and their relation to both anxiety and affective disorders
(Degenhardt et al., 2001). Data for this study were obtained as part of a large nationwide
survey, the Australian National Survey of Mental Health and Well-Being (NSMHWB).
Participants were contacted using random sampling techniques (78% response rate).
Participants consisted of a representative sample from the Australian general adult
population. Approximately 5% of participants reported using marijuana more that 5 times
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within that past year without meeting criteria for a DSM-IV marijuana use disorder.
However, a remaining 0.8% and 1.5% of the participants met criteria for marijuana
abuse and dependence, respectively. At a zero-order level, findings indicated that
among those who met criteria for marijuana dependence, 17% also met criteria for an
anxiety disorder. This finding is contrasted with only 5% of those who did not use
marijuana who met criteria for an anxiety disorder. Once demographic characteristics
(e.g., gender, age) as well as neuroticism and other drug use were entered into the
model as covariates, this association became non-significant. Yet, because this
investigation collapsed across anxiety disorders diagnoses, specific effects unique to
one type of anxiety problem may have been missed (e.g., panic attacks compared to
social phobia).
In the only other available epidemiological study evaluating marijuana use and
panic, Zvolensky, Bernstein, Sachs-Ericsson, Schmidt, Buckner, and Bonn-Miller (2006)
evaluated lifetime associations between marijuana use, abuse, and dependence and
panic attacks after controlling for alcohol abuse, polysubstance use, and demographic
variables. Data for this study were obtained as part of a large statewide survey, the
Colorado Social Health Survey (CSHS). Participants were contacted using randomly
sampled household addresses (72% response rate) and interviews took place in
participants‟ homes. Participants consisted of a representative sample from the Colorado
general adult population (n = 4,745; 52% female). The Diagnostic Interview Schedule
(Robins, Helzer, Croughan, Williams, & Spitzer, 1981) was administered to obtain
diagnoses. After controlling for polysubstance use, alcohol abuse, and demographic
variables, lifetime history of marijuana dependence, but not use or abuse, was
significantly related to an increased risk of panic attacks. Additionally, among
participants reporting a lifetime history of both panic attacks and marijuana use, the age
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of onset of panic attacks (M = 19.0 years of age) was significantly earlier than for
individuals with a lifetime panic attack history but no marijuana use (M = 27.6 years of
age). These results suggest that lifetime marijuana dependence, but not use or abuse, is
significantly associated with an increased risk of panic attacks.
The representative marijuana-panic studies add another degree of
methodological rigor to the community-recruited cross-sectional studies. These
investigations provide some (necessarily limited) evidence that only more severe forms
of marijuana use may be related to panic attacks, although the data overall are not
comprehensive. These studies both involve secondary analyses of larger data sets and
were therefore not deigned, specifically, to address marijuana-panic associations. Given
this context, from my perspective, there appears to be a reasonable degree of
consistency across both sets of cross-sectional studies; and observed effects warrant
further scholarly attention. Yet, while useful as an entry-level “benchmark” for gauging
marijuana-panic relations, it should not be lost that the above cross-sectional studies
cannot disentangle temporal order and therefore leave open issues related to (1) the
directionality of the observed effects and (2) the time sequence of marijuana-panic
associations.
Prospective studies. Whereas cross-sectional data document a concurrent
association, prospective study is needed to explicate temporal time course. I am aware
of only two prospective studies on marijuana use and panic variables.
In the earliest reported study, the nature of marijuana use and anxiety symptoms
(as well as depressive symptoms) was examined (Brook, Rosen, & Brook, 2001). In the
study, the investigators referred to anxiety and depressive symptoms collectively as
“distress” variables and did not attempt to develop separate theoretical models for
parsing their potential unique effects apart. This study involved a two time (1-2 year
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interval) prospective study of Colombian adolescents (n = 2,226; 48.2% female) aged 12
to 17 years old. Data were examined in both directions; adolescent distress predicting
later marijuana use and adolescent marijuana use predicting later distress. Findings
indicated that marijuana use in early adolescence significantly predicted later anxiety
symptoms (Time 2) after controlling for distress and interpersonal functioning in earlier
adolescence (Time 1). These significant findings did not exist for depressive symptoms,
though a trend seemed to emerge. These findings were specific to marijuana predicting
later anxiety and were not apparent when anxiety symptoms were tested as a predictor
of later marijuana use. These findings suggest marijuana use is systematically related to
the future development of anxiety symptoms, but does not address associations with
panic attacks or diagnosable anxiety conditions.
In another more recent investigation, Zvolensky, Lewinsohn, Bernstein, Schmidt,
Buckner, Seeley, & Bonn-Miller (in press) prospectively evaluated marijuana use, abuse,
and dependence in relation to panic attacks and panic disorder. Participants at the start
of the study were adolescents (n = 1,709) with a mean age of 16.6 years (SD = 1.2) and
were re-assessed 1 year later, and then again, as young adults (Mean age = 24.2 years,
SD = 0.6). Results indicated that cannabis use was significantly prospectively associated
with an increased odds for the development of panic attacks and panic disorder (OR =
2.5, p < .05, 95% CI = 1.2-5.3, and OR = 2.6, p < .05, 95% CI = 1.04-6.5, respectively).
Similar findings also existed for cannabis dependence and panic attacks and panic
disorder (OR = 3.7, p < .01, 95% CI = 1.4-9.3, OR = 4.9, p < .01, 95% CI = 1.7-14.0).
Cannabis abuse, however, was not associated with a change in the odds of panic
attacks or panic disorder incidence. The lack of an effect could possibly be due to
measurement problems associated with marijuana abuse; namely, very few cases of
abuse were noted in this study. An interpretative caveat to this investigation was that
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cannabis was not found to be incrementally associated with the development of panic
after daily cigarette smoking was controlled. These data suggest marijuana use and
dependence are significantly and prospectively associated with an increased risk of
panic attacks and panic disorder from adolescence through early adulthood. However,
the marijuana-panic psychopathology effects do not appear stronger than the link
between cigarettes and panic. No analysis was completed to evaluate the opposite
scenario (marijuana contributing to panic psychopathology over and above daily
cigarette use) or the effects of both forms of drug use on panic variables.
The two prospective studies on marijuana-anxiety associations are broadly, but
not uniformly, consistent with the cross-sectional work reviewed earlier. There is some
evidence that marijuana use (and possibly more severe or heavier forms of use)
measured earlier in the time span is related to an increased risk for panic
psychopathology in the future. There does not seem to be evidence that panic
contributes to later development of marijuana use or its disorders, although this has
received little empirical attention. These investigations are helpful to informing the extant
knowledge base, but, again, are limited in scope and focus. Indeed, both studies involve
secondary analysis of existing data and were thus not solely designed to address
marijuana-panic associations.
Key limitations of existing work. Taken together, though there is an emerging
literature on marijuana and its role in anxiety and panic processes, it is at a very early
developmental stage. Thus, it is perhaps not surprising that there are notable limitations
to the body of research in need of improvement from a variety of vantage points. I
believe that there are at least two key methodological challenges that could be improved
upon, and by extension, provide a higher-degree of scientific scrutiny to the issues at
hand. Please note that this discussion focuses on two formative limitations of extant
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work and is not intended to represent a comprehensive discussion of all possible
limitations of past studies.
First, each of the previous cross-sectional and prospective investigations has
utilized self-report or structured interviews to index anxiety and panic states. Though this
approach marks an improvement from earlier work that did not use validated
instruments, it is problematic in the sense that it capitalizes on shared method variance
and does not speak to the theoretically-based multidimensional nature of anxiety and
fear processes. Thus, future work would benefit from including a theoretically-driven
assessment of multiple aspects of anxious and fearful states. Such an approach is
necessary to more accurately measure anxiety factors and to support the development
of a cross-system perspective on the nature (specificity) of potential marijuana-panic
associations.
Second, previous investigations addressing marijuana-panic associations have
largely been field-based. There has been no laboratory study among adults. Though a
natural starting point, solely relying on field-based research methodology does not
permit a “real time” examination of anxiety and fearful states as they are elicited by
bodily perturbation. Here, it is important to remember that even the most sophisticated
real-world or prospective monitoring techniques employed in naturalistic conditions invite
a range of interpretation-related errors (McNally, 1999). For example, participants may
misinterpret anxiety states for panic attacks or vice versa. As a second example,
participants may not be fully aware of certain anxiety states and therefore be unable to
precisely identify the onset, duration, or offset of such states. To address these types of
issues, the utilization of laboratory paradigms that elicit bodily sensations under
controlled conditions may be a worthwhile next research step and help index the
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potential merit of marijuana-panic associations with a higher degree of methodological
rigor.
Overall, enhancing the methodological approach to explicating a potential
marijuana-panic association is a “first step” in a larger sequence of research processes.
That is, before more firm conclusions can be drawn and more advanced conceptual
models of interplay between potential operative variables can be forwarded, it is
necessary to ensure that there is, in fact, a relationship between certain forms of
marijuana use and panic processes. Once this matter is resolved, then, researchers can
evaluate other more advanced “main effect” oriented questions such as those dealing
with malleability, and ultimately, integrate such work with multi-risk factor models (e.g.,
addressing moderating and mediating processes).
Theoretical Integration
Given the noted marijuana-panic associations, it is important to integrate past
work and offer a conceptual basis as to how certain types of marijuana use would relate
to panic attacks and anxious responding to bodily sensations more generally. From the
outset, it is important to clarify that I am operating from a theoretical position that focuses
on the potential role of certain types of marijuana use in relation to panic processes. This
“risk factor approach” naturally represents only one possible pathway and there may be
others worthy of further pursuit (e.g., the role of panic factors in relapse to marijuana
during quit attempts).
Drawing from empirical observation, it appears – from cross-sectional and
prospective designs – that heavier use or more severe forms of marijuana use are
possibly more likely to show systematic relations to panic attacks and panic disorder. It
is not fully clear whether frequency of marijuana use or severity of problematic types of
use is the better explanatory variable for panic-relevant phenomena. Moreover, though it
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is presently empirically unclear why such types of marijuana use may relate to panic,
there may be at least three possible, as of yet only theoretically postulated, pathways;
these pathways should not be considered mutually exclusive.
Theoretical pathway one. Drawing from work on tobacco and panic, one pathway
may be focused on repeated affect-relevant learning with aversive interoceptive cues
(Zvolensky & Bernstein, 2005). Over long periods of time, heavier forms of marijuana
use (e.g., dependence) can lead to increased risk of bodily sensations and aversive
internal states via a number of routes, including withdrawal symptoms (Budney & Moore,
2002; Budney et al., 1999; Budney et al., 2003) and physical illness such as respiratory
disturbances (Bloom et al., 1987; Fligiel et al., 1997; Tashkin, 1999). Exposure to these
types of aversive stimuli may facilitate learning that internal cues can be personally
harmful and anxiety-evoking (Barlow, 2002). A frequent marijuana user may experience
interoceptive symptoms due to their drug use, and these symptoms may be associated
with escalating anxiety.
From this type of perspective, there is a “pairing” of anxiety to bodily stimuli. For
example, an individual who experiences aversive marijuana-related withdrawal
symptoms may associate escalating anxiety states with internal cues. As such, they may
become more sensitive and emotionally reactive to internal cues, perhaps promoting
greater risk for experiencing a panic attack. Thus, more frequent or severe users of the
drug would be more apt to experience panic problems. While intriguing, this model also
would seemingly predict that more severe forms of marijuana use would lead to panic
disorder. Extant data are not consistent with this perspective, and hence, may urge
some degree of caution in using it as an exclusive conceptual guide. This model also
assumes that panic onset would occur only after longer histories of use, predicting that
bodily sensations related to heavier forms of use would be the mediating processes; an
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account consistent with Zvolensky and colleagues‟ (in press) most recent prospective
investigation.
Theoretical pathway two. A second pathway may pertain to the nature of
marijuana use motives among regular users of the drug. Here, it is noteworthy that
among more frequent users of marijuana, drug use serves important affect regulatory
functions (Bonn-Miller, Zvolensky, & Bernstein, 2007; Comeau, Stewart, & Loba, 2001).
Specifically, individuals who use marijuana more frequently tend to be motivated to use
the drug for affect regulation purposes (Simons, Correia, & Carey, 2000). For example,
these marijuana users report using the drug to help cope with aversive emotional states
like anxiety and fear (Simons et al., 2000). Although the objective mood-dampening
qualities of marijuana use are not fully known, among experienced users of marijuana,
available, albeit limited, laboratory work suggests that the use of the drug can, in fact,
lessen acute states of anxiety (Mathew, Wilson, & Tant, 1989). Thus, for both perceived
and potentially objective reasons, certain (perhaps especially emotionally vulnerable)
regular users of marijuana may use the drug to cope with anxiety-related states. In the
absence of other more adaptive coping strategies (e.g., not engaging in drug use, but
rather, non-drug related behavior), experienced marijuana users may therefore
potentially learn to rely on the drug to manage anxiety states in the short-term (i.e.,
proximal circumstances).
Recent marijuana-anxiety research would support such a prediction. For
example, Mitchell, Zvolensky, Marshall, Bonn-Miller, and Vujanovic (2007) found
marijuana used to reduce negative affect was uniquely related to a range of affective
vulnerability factors (e.g., anxiety sensitivity, anxious arousal, and negative affectivity)
among current marijuana users (n = 131 young adult marijuana users). Specifically, the
motivation to smoke to reduce negative affect (coping motives) was significantly related
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to anxiety sensitivity and negative affectivity; the observed significant effects were above
and beyond other theoretically-relevant factors (e.g., gender, past 30-day marijuana use,
alcohol consumption, and daily tobacco use). These findings provide support for the
possibility that motives underlying marijuana use may theoretically be involved in
shaping affective vulnerabilities and outcomes. That is, aside from drug-specific use
effects, learning to rely on drug use as a form of coping strategy may “mark” or perhaps
explain risk for affective vulnerability. This type of account would be fully consistent with
avoidance learning models of anxiety vulnerability, whereby response strategies aimed
at rigidly (consistently or in a context-insensitive fashion) eliminating or preventing
anxiety states is related to an increased risk of panic problems (see Feldner, Zvolensky,
& Leen-Feldner, 2004, for a review). More specifically, this type of perspective suggests
that there are important associations between certain marijuana use motives and negative
affective states and that such relations are not attributable to other marijuana use factors
(e.g., rate of use). Such a perspective also would be consistent with a gradient of use
effect, whereby greater potential for panic attacks would be evident among more frequent
or severe users. A possible challenge to this type of account is that it is not clear why the
effects would be specific to panic states and not other negative affective processes as well.
Theoretical pathway three. A final pathway worthy of consideration pertains to
the social ecology of marijuana use. As described earlier, there is a wide range of
powerful effects related to marijuana use that includes changes to sensory-motor as well
as somatic processes. Thus, it is reasonable to speculate that being “high” can be
considered a potentially “challenging event” for certain types of (vulnerable) people.
From a larger developmental perspective, then, users who have negative experiences
with sensations induced from marijuana (and perhaps even panic attacks) early in the
history of their marijuana use would be likely to rapidly discontinue using the drug (Hall
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et al., 1994). That is, outside of social peer-oriented pressure, it would be hard to
imagine why an individual who experiences aversive sensations would continue to use
marijuana after such an experience. I would indeed expect that the vast majority of these
early-negative experience marijuana users would not continue using the drug.
Yet, those persons who do not experience significant anxiety or other negative
consequences from marijuana use early on may be more apt to continue to use the
drug. As their use continues, they are more apt to experience negative interoceptive
effects (pathway one described above) and learn to use the drug for affect-regulatory
reasons (pathway two). Outside of these other pathways, however, research suggests
that even experienced and frequent marijuana users typically report “negative”
experiences with the drug. For example, such negative experiences include states of
paranoia, escalating anxiety, and aversive internal experiences more generally (Hall et
al., 1994). It is not possible to know whether these “aversive internal experiences” are
panic attacks per se in such studies because these studies do not assess for panic
attacks. It is nonetheless interesting that many of these heavier users appear to attribute
such symptoms to the situations in which they were using (e.g., social context) rather
than the drug itself (Reilly, Didcott, Swift, & Hall, 1998). For example, Reilly et al. (1998)
reported that among 269 long-term users of marijuana, approximately 20% reported
acute negative emotion-specific effects related to the drug use. These data may indicate
that even among frequent marijuana users, use of the drug under certain conditions
(contexts) may be related to acute, adverse emotional experiences like panic attacks.
These persons could attribute such reactions to the conditions rather than the drug use,
as they have had numerous „successful‟ trials in their drug use careers among other
factors (e.g., presence of distracters in the specific situations). As applied to panic, this
would suggest that these individuals “develop” (cued) panic attacks, but because they
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have a reason for them, they do not experience them as unexpected or unpredictable –
the sin qua non of panic psychopathology. In total, the third possible pathway may
represent problematic experiences across different contexts among frequent users of the
drug.
Summary. See Figure 1 for a graphical representation of the three pathways
identified here. While these pathways are not mutually exclusive, and may in fact be
related to a larger dynamic process of use, they do converge on a similar theme:
namely, that more frequent or severe forms of marijuana use should be related to an
increased risk of panic attacks. A prediction from such perspectives would be that,
regardless of the exact mechanism of action, more frequent or severe users of
marijuana should theoretically be at greater risk for responding with anxiety and fear to
aversive internal cues than individuals without such a history or individuals with lowerfrequency or less severe use.
Current Study
Global aim. The overarching aim of the present study was to evaluate anxious
and fearful responding to a biological challenge procedure as a function of different
levels of marijuana use among adults. This study was oriented a priori on a “main effect”
analysis with the primary goal of bringing a greater level of methodological rigor to the
larger marijuana-panic empirical literature. In the current study, a multimethod
assessment protocol was employed to track relevant types of emotional responding
across and between levels of analysis.
Participant categorization. I studied three separate groups of theoretical
relevance: (1) adults who have no history of marijuana use (defined as no history of
marijuana use at all; I refer to this group as “no marijuana history”), (2) those who
currently regularly use marijuana at relatively low rates (defined as no more than 3
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occasions of use per month for the past 12 months; I refer to this group as “regular, lowfrequency use”), and (3) those who are heavy users (defined as those using at least 5
times per week for the past 12 months; I refer to this group as “regular, high-frequency
use”) of marijuana. Please see Table 3 for a listing of the screening criteria for these
groups.
This approach to participant categorization was theoretically-driven and viewed
as potentially more powerful at this stage of research development than a strict DSM
categorization (i.e., use, abuse, and dependence). Specifically, from the theoretical
model proposed, greater frequency of use should increase the risk of bodily sensations
via a number of routes (e.g., withdrawal symptoms, physical illness). It is not yet clear
how these interoceptive processes are specifically related to use, abuse, and
dependence criteria per se. Thus, strictly categorizing participants on the basis of use,
abuse, and dependence criteria may potentially miss a formative panicogenic
mechanism(s) from the theoretically-driven perspective offered here. As such, I
conservatively opted to classify participants as a function of frequency of use, and at the
same time, conduct diagnostic interviews to determine DSM criteria. Current alcohol and
tobacco use, as well as gender were matched for each of the three groups prior to the
challenge. Participants also were screened for major physical health problems (e.g.,
cardiovascular disease) prior to their inclusion in the study to ensure that groups did not
differ in relation to pre-existing health problems and to prevent adverse complications
that could arise from participating in the study. This is a standard approach in biological
challenge research that still permits disease states that are not chronic in nature (e.g.,
bronchitis; Zvolensky & Eifert, 2000).
Hypotheses. Based upon the present conceptual and empirical analysis, there
were a number of interrelated hypotheses for the investigation. First, in regard to self-
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report of emotional distress, it was hypothesized that regular, heavy marijuana users
would report greater levels of (a) post-challenge anxiety focused on bodily sensations
(operationalized by post-challenge Subjective Units of Distress ratings (SUDs; Wolpe,
1958) and (b) post-challenge intensity of endorsed panic attack symptoms
(operationalized by the Diagnostic Symptoms Questionnaire (DSQ); Rapee, Brown,
Antony, & Barlow, 1992) compared to the other two groups, which were expected not to
differ from one another. Second, in regard to avoidance responding in relation to bodily
stress, it was expected that heavy marijuana users would show greater desire to avoid
future exposure to somatic perturbation (operationalized as desire to participate in future
CO2 –based investigations, and hence, analogous to “behavioral avoidance”) postchallenge than each of the other two groups. No differences were expected between the
non-users and low regular users. Finally, in terms of physiological responding, it was
expected that all three groups would show similar levels of respiration rate during the
challenge, but that regular heavy marijuana users would show greater heart rate
reactivity (operationalized as heart rate change from baseline to post-challenge)
compared to the other two groups.
Collectively, these hypotheses were driven by research that has linked heavier
levels of marijuana use to greater degrees of anxiety vulnerability, especially anxious
arousal symptoms and panic attacks (Bonn-Miller, Zvolensky et al., 2005; Zvolensky,
Bernstein, Marshall et al., 2006). These types of symptoms conceptually map on to
panic vulnerability and therefore provided an initial basis for expecting the heavy
marijuana using group to be more emotionally responsive to bodily sensations induced
via a biological challenge.
Method
Participants
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The sample consisted of 96 participants (32 (15 female) participants per cell;
mage = 22.60, SD = 9.01, 45 females) who were recruited from the greater Burlington,
Vermont community. Participants were recruited through the general community and
university communities via newspaper ads and flyers advertising a laboratory study on
„emotion.‟ Overall, 95.8% of the sample was Caucasian, 1.1% identified themselves as
“other,” while 3.1% of participants chose not to specify their race. In terms of highest
level of education completed, 2.1% did not graduate from high school, 76.0% graduated
from high school, 12.5% reported partial college education, 2.1% graduated from a 2year college, 4.2% graduated from a 4-year college, 2.1% reported partial graduate
education, and 1% reported some graduate degree.
Within the sample, 46.9% of participants identified themselves as smokers;
smoking an average 15.07 (SD = 6.85) cigarettes per day. When examined at a group
level, each marijuana group contained 15 smokers. Within group 1 (no history of
marijuana use), smokers reported averaging 15.60 (SD = 4.26) cigarettes per day,
whereas smokers in group 2 (low rates of current marijuana use) reported smoking an
average of 16.27 (SD = 9.48) cigarettes per day. In the third group (high marijuana use),
smokers reported averaging 13.33 (SD = 5.88) cigarettes per day. See Results Section
for further details.
Approximately 97% of participants reported current alcohol use, averaging
between 5 and 6 drinks per occasion, 2 to 4 times per month. Regarding alcohol use
problems, approximately 64% of the entire sample reported at least moderate alcohol
use problems, as indexed by a score of 8 or greater on the Alcohol Use Disorders
Identification Test (AUDIT; Babor, de la Fuente, Saunders, & Grant, 1992). At a group
level, each group contained 31 individuals who described themselves as alcohol users.
Among those with no history of marijuana use (group 1), participants reported drinking
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an average of 2 to 4 times per month, with approximately 3 to 4 drinks per occasion, with
approximately 41% reporting at least moderate alcohol use problems. Those who
reported regular low rates of marijuana use (group 2) reported higher rates of alcohol
use, averaging between 5 and 6 drinks per occasion, 2 to 3 times per week, as well as
higher rates of alcohol use problems (69%). A similarly high rate of alcohol use was
observed among the regular high marijuana use group (group 3), though this group had
the highest percentage of participants reporting at least moderate alcohol use problems
(81%). See Results Section for further details.
Exclusionary criteria for the investigation included: (1) current axis I
psychopathology; (2) current use of psychotropic medication; (3) current suicidality or
homicidality; (4) current or past chronic cardiopulmonary illness (e.g., chronic obstructive
pulmonary disease; severe asthma), (5) current, acute respiratory illness (e.g.,
bronchitis), (6) seizure disorder, cardiac dysfunction, or other serious medical illness
(e.g., history of seizures, emphysema); (7) pregnancy (specific to females); and (8)
limited mental competency, inability to give informed, written consent. These
exclusionary criteria help ensure (1) the safety of participants during the challenge and
(2) the equivalence of the groups in terms of “background characteristics” that could
theoretically serve as alternative explanations to any observed effects. For example, if
individuals with current axis-I conditions were included, those in the more frequent
marijuana use group may have an overrepresentation of these conditions relative to the
other groups. Although it may have been useful to extend this exclusionary criteria
approach to other factors of interest (e.g., tobacco use and alcohol use), such an effort
would have (1) likely significantly diminished the generalizability of the present findings
and (2) been difficult to carry out from a practical perspective due to the high rates of
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overlap between marijuana use and these factors. As such, I matched across groups for
these others factors; please see Table 3 for a listing of each of the three groups.
The screening criteria that were employed in the present investigation have been
successfully used in previous studies involving CO2 administration (Zvolensky, Eifert, &
Lejuez, 2001) and were assessed by validated medical and psychiatric history devices
(please see Measures section). Upon request, all interested individuals meeting
psychiatric exclusionary criteria were referred to our department clinic that is housed in
the same building as our laboratory. Eligible participants were compensated monetarily
for their participation. Please see the Procedure Section for further details.
Measures
Pre-experimental Interview Assessments
Structured Clinical Interview-Non-Patient Version for DSM-IV (SCID-NP).
Lifetime and current prevalence of panic attacks, current marijuana abuse and
dependence (with the inclusion of substance withdrawal criteria as defined by the DSMIV for other drugs and as assessed by the SCID-NP for other drug classes), Axis I
diagnoses, suicidal ideation, and medication use were determined using the SCID-NP
(First, Spitzer, Gibbon, & Williams, 1995). The SCID-NP was used because subjects in
the study were not identified as being a clinical population per se (i.e., recruited through
the community). Adequate reliability of the Axis I SCID has been demonstrated generally
(Spitzer & Williams, 1986) and in Dr. Zvolensky‟s laboratory, specifically, for both
psychological disorders and substance use disorders (Zvolensky, Leen-Feldner et al.,
2004). Demographic characteristics such as age, gender, ethnicity, marital status, and
years of education also were collected using the SCID-NP.
Medical History Screening Interview (MHSI). The MHSI was used to examine (a)
current or past cardiopulmonary (chronic) illness (e.g., chronic obstructive pulmonary
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disease; asthma); (b) current acute respiratory illness (e.g., bronchitis); (c) possibility of
being pregnant (by self-report); (d) seizure disorders; (e) current or past psychotropic
medication use; (f) suicidal ideation; and/or (g) limited mental competency and the
inability to give informed, written consent. These screening criteria have been
successfully used in previous biological challenge research (e.g., Zvolensky, Eifert, &
Lejuez, 2001) and are assessed by a validated medical history screening interview
developed explicitly for this purpose (Forsyth & Eifert, 1998).
Pre-experimental Tobacco, Marijuana, and Alcohol Measures
Smoking History Questionnaire (SHQ). The SHQ is a well-established tool that
includes items pertaining to smoking rate, age of onset at initiation, years of being a daily
smoker, and quit history. The SHQ has been successfully used in previous studies as a
descriptive measure of smoking history (Zvolensky, Schmidt et al., 2005). I used the
smoking rate item from the SHQ as a primary index of “smoking exposure.” The SHQ
also was employed to provide a detailed descriptive analysis of the tobacco use histories
more generally of participants in the present investigation.
Marijuana smoking history and pattern were assessed with the Marijuana
Smoking History Questionnaire – Version 2 (MSHQ). The MSHQ is a self-report
instrument that includes items pertaining to marijuana smoking rate (lifetime and past 30
days), quantity of marijuana smoked, age of onset at initiation, years of being a regular
marijuana smoker, and other descriptive information (e.g., number of attempts to
discontinue using marijuana). It was modeled after the SHQ. The MSHQ has been
employed successfully in the past (Bonn-Miller et al., 2005; Zvolensky, Bonn-Miller et al.,
2006). In the present investigation, the MSHQ was used to provide a detailed descriptive
analysis of the marijuana smoking history characteristics of the sample.
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Motives for marijuana use were assessed with the Marijuana Motives Measure
(MMM; Simons, Correia, Carey, & Borsari, 1998), a 25-item measure on which
respondents indicate, on a 5-point Likert-type scale (1 = "almost never / never" to 5 =
"almost always / always"), the degree to which they have smoked marijuana for a variety
of possible reasons. Factor analysis of the scale indicates that it has five first-order
factors entitled Coping (“To forget my worries,” “To cheer me up when I am in a bad
mood”), Expansion (“To know myself better,” “To expand my awareness”), Conformity
(“Because my friends pressure me to use marijuana,” “To fit in the group I like”),
Enhancement (e.g., “Because I like the feeling,” “Because it‟s fun”), and Social motives
(“Because it helps me enjoy a party,” “Because it improves parties and celebrations”)
(Simons et al., 1998). The MMM has high levels of internal consistency for each of the
five factors (range of alpha coefficients: .86 to .93) and has been successfully used in
the past to tap motivation for using marijuana (Simons et al., 1998).
Alcohol Use Disorders Identification Test (AUDIT). The AUDIT is a 10-item
screening measure developed by the World Health Organization to identify individuals
with alcohol problems (Babor, de la Fuente, Saunders, & Grant, 1992). Most items are
rated on a 5-point Likert scale from (0) never to (4) daily or almost daily. Scores range
from 0-40 with a score of 8 indicating moderate alcohol use problems. Major areas of
problematic drinking that are assessed include: alcohol consumption, drinking behavior
(dependence), adverse psychological reactions, and alcohol-related problems. There is
a large body of literature attesting to the psychometric properties of the AUDIT (e.g.
Saunders, Aasland, Babor, de la Fuente, & Grant, 1993). For example, the AUDIT has
consistently demonstrated good levels of internal consistency (alpha coefficient: .81;
Kokotailo, Egan, Gangnon, Brown, Mundt, & Fleming, 2004). In the present
investigation, I used the frequency and quantity items of the AUDIT to index alcohol
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consumption as well as coded for history of problems with alcohol use (a secondary
index of alcohol problems in addition to the SCID-NP interview data).
Laboratory Challenge Measures
Subjective Units of Distress Scale (SUDs; Wolpe, 1958). The SUDs was used to
index pre and post experimental self-reported anxiety. Participants indicate how anxious
they currently are on a scale ranging from 0 (no anxiety) to 100 (extreme anxiety). This
is a well-established assessment of self-reported anxiety during laboratory provocations
(e.g., Zvolensky, Lejuez, & Eifert, 1998).
Diagnostic Symptoms Questionnaire (DSQ; Rapee, Brown, Antony, & Barlow,
1992). The DSQ is a 16-item measure of the occurrence and intensity of DSM-IV panic
symptoms. Specifically, the DSQ lists DSM-IV panic symptoms (both somatic and
cognitive) and yields a composite score for mean intensity level of symptoms
experienced. The mean intensity scores for the DSQ are made on a nine-point Likert
type scale (0 = not at all to 8 = very strongly felt) and derived by averaging the
symptoms endorsed (including zeros for those symptoms not endorsed). The DSQ has
successfully been used in challenge studies to index panic symptoms in this manner
(Sanderson, Rapee, & Barlow, 1989).
Behavioral Avoidance. In order to index behavioral avoidance post-challenge,
participants‟ willingness to participate in another CO2 administration was evaluated by a
paper-and-pencil questionnaire at the end of the recovery period. This item asked
participants to rate their level of willingness to participate in another CO2 administration
study. Specifically, at the end of the recovery phase, participants were told that other
CO2 studies would be recruiting individuals for participation within the next 2 weeks via a
written statement on the questionnaire. Then, participants were asked to indicate their
willingness on a 100-point Likert-style questionnaire intended to assess participants‟
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interest in returning for another CO2 investigation (0 = no desire to participate; 100 =
definite desire to participate). This type of index has been utilized successfully in the
past with biological challenge paradigms, and such work has shown that this measure is
related to avoidance due to fear and is not correlated with boredom or other related
emotional states such as frustration (Eifert & Heffner, 2003).
Materials and Apparatus
Laboratory sessions were conducted in a 3-meter X 3-meter experimental room
in the Department of Psychology at the University of Vermont. Participants sat at a desk
supporting a Dell Pentium computer with color monitor, which was turned off during the
entire duration of the procedure. After completing physiological hookup and providing
experimental instructions (see Procedure for details), the experimenter ran and observed
study participants from an adjacent control room containing an apparatus designed to
provide participants with either room air or a mixture of 10% carbon dioxide-enriched air.
Carbon dioxide was stored in a 24-inch diameter hospital grade latex bag and
delivered via 5-centimeter tubing to a positive-pressure C-pap mask worn by the
participant. In addition to a one-way mirror, a video and audio monitoring system allowed
the experimenter to observe all session events. It should be noted here that the risks for
the CO2 administration include temporary discomfort that may include racing heart
sensations, increased breathing rate, shortness of breath, and dizziness. These effects
are entirely harmless and painless; they disappear quickly when participants return to
breathing normal room air. In one recent investigation, for example, a large sample of
participants (n = 125) underwent recurrent CO2 administration or room air (Prenoveau,
Forsyth, Kelly, & Barrios, 2006). These participants were then prospectively monitored
for up to 1 year. Results of this controlled investigation indicated that the percentage of
people who developed subsequent panic attacks did not differ by condition. Thus, these
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data indicate that CO2 administration does not increase the risk of subsequent panic
attacks in a nonclinical population, and hence, is a safe paradigm for use in research.
The CO2-inhalation was utilized as the panic-relevant challenge procedure because it
can be safely employed, its parametric properties are well studied, and it can reliably
produce bodily arousal and psychological symptoms relevant to panic states in
nonclinical and clinical samples (Zvolensky & Eifert, 2000). Moreover, it has been safely
and effectively used in previous work with adults across numerous research sites without
incident for decades (e.g., Gorman et al., 2001).
A J&J Engineering I-330-C2 system was used to digitally record physiological
data on-line at a sample rate of 1024 samples per second across all channels using J&J
Engineering Physiolab Software. Two physiological variables were examined for the
current study (Venables & Christie, 1980): respiration rate (a measure of breaths per
minute), and heart rate (a measure of beats per minute). Respiration rate was obtained
using a Pneumograph sensor cable with PS-2 sensors as a manipulation check. The
sensors were placed across the chest and secured with a Velcro strap, allowing a
measure of chest excursion during respiration. Raw electrocardiogram data were
collected with disposable Ag/AgCl electrodes placed in a standard bilateral configuration
on the palmar side of each wrist. Data were processed through a 1-100Hz bandpass
filter designed to maximize R-wave frequency.
Procedure
Please see Figure 2 for a schematic diagram of the study procedure. Community
and university-based populations were the focus of the recruitment process. Specifically,
participants were recruited through newspaper advertisements and flyers that described
a laboratory study on „emotion.‟
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Interested persons responding to advertisements who contacted the research
team were given a detailed description of the study over the phone. After providing
verbal consent, the SCID-NP (screener) was administered by a trained research
assistant via telephone. Those meeting inclusionary criteria were scheduled to attend a
single laboratory session. Upon arrival, participants completed a written informed
consent, which indicated that the procedure involved a single 4-min 10% CO2-enriched
air presentation. Participants then completed the pre-experimental measures. Each
participant was then introduced to the laboratory setting for the challenge procedure.
During the session, participants sat alone in the 8-ft x 12-ft sound attenuated
experimental room, which contained a computer, chair, desk, and intercom that allowed
participants to communicate freely with the experimenter in the adjacent room.
Participants were seated in front of a table, on which a binder with the experimental,
paper-pencil self-report measures was placed. Once the electrodes were attached
standardized instructions were provided, including:
“Following the (10 minute) adaptation period, we will start the experimental portion
of the study which will last approximately 4 minutes. During this period you will
receive several inhalations of CO2-enriched air that may produce physical and
mental sensations associated with bodily arousal. You may temporarily feel your
heart racing, your palms might be sweaty, you might feel dizzy, and you might
have some breathing problems.”
The study consisted of two phases. The first phase involved a 10-min baseline
adaptation period during which participants sat quietly in the testing room breathing
regular room air. Participants completed SUDS ratings at the beginning and end of the
adaptation period. Phase two consisted of the automated delivery of one 4-min 10%
CO2-enriched air presentation. Participants completed a SUDs rating and the DSQ
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immediately after completing the 4-minute challenge exposure. Physiological data were
gathered continuously across both phases. After the study, participants were debriefed
and compensated $20.
General Analytic Approach
Means and standard deviations were first computed for each of the criterion
variables and baseline characteristics (e.g., smoking rate, alcohol use) in relation to the
three marijuana groups (no use, regular, low-frequency use, and regular, high-frequency
use). A one-way ANOVA was then utilized to formally evaluate for group differences.
To test hypothesis 1, I examined the relation between the three marijuana use
groups and SUDs and DSQ ratings via two separate analyses of variance (ANOVA‟s). In
the first analysis, the difference score between the immediate pre and post-challenge
SUDs ratings was the criterion variable, and the predictor variable was marijuana use
levels (trichotomously coded; 1 = no use, 2 = low use, and 3 = heavy use). In the second
analysis, total intensity of panic attack symptoms were calculated (via summation of
each symptom‟s intensity rating) and employed as the criterion variable, and marijuana
use levels remained as the predictor variable in an identical fashion to the SUDs
analysis.
To test hypothesis 2, similar analyses were conducted. An ANOVA was
employed, with the criterion variable as avoidance responding (operationalized as desire
to participate in future CO2 –based investigations; rated on a 100 point scale) and the
independent variable as marijuana use level (coded trichotomously, as noted above).
Finally, to test hypothesis 3, both the respiration and heart rate reactivity criterion
variables were first computed by creating a difference score between the average
reactivity during the last minute of baseline (from 240 data points; one every ¼ second)
and the reactivity during the first minute of post-challenge recovery (from 240 data
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points; one every ¼ second). Once these two variables were computed, two ANOVA‟s
were employed. One used respiration rate as the criterion variable and the other had
heart rate reactivity as the criterion variable. The independent variable for each ANOVA
was the trichotomously coded marijuana use variable.
Results
Data Reduction Approach and Manipulation Check of Provocation Paradigm
The first step in the data analysis procedure involved an evaluation of the utility
of the challenge paradigm to elicit panic-relevant responsiveness. Thus, after screening
for outliers due to sampling error (e.g., participant movement), the integrity of the 10%
CO2 – enriched air administered for 4-min to elicit anxiety and physiological
responsiveness was examined. Standard data reduction strategies employed in past
biological challenge work were employed for the physiological data screening and
reduction process (Zvolensky et al., 1998); specifically, any non-readable data (i.e.,
missing data due to human error such as an electrode falling off a participant) were
eliminated. The data also were inspected for falling beyond an „expected range‟ per the
recommendations of Venables and Christie (1980). If data were at an extreme (e.g.,
greater than 230 beats per minute and lower than 40 beats per minute), they were
removed due to the likelihood of containing a sampling error.
A paired-samples t-test indicated that the mean SUDS score post-challenge (M =
52.03, SD = 26.20) was significantly greater than the mean SUDS score pre-challenge
(M = 20.85, SD = 18.70), t(95) = -11.23, p < 001). In addition, paired-samples t-tests
indicated that the mean heart rate and respiration rate scores post-challenge (M = 92.39,
SD = 13.46; M = 19.71, SD = 3.70 respectively) were significantly greater than at the
final minute of the pre-challenge time period (M = 81.43, SD = 10.95; M = 16.91, SD =
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3.41 respectively), t(94) = -8.49, p <.001; t(83) = -5.78, p < .001 respectively. All of the
manipulation check-oriented analyses were collapsed across the groups.
Success in Matching Procedure
The second step in data analysis activities involved evaluating the matching
procedure employed across the groups to formally inspect my success in „equating‟
groups on some key characteristics prior to the challenge exposure. As initially
proposed, matching of gender, alcohol use and tobacco use was globally successful
(please see Table 4 for a case by case breakdown). Specifically, each group contained
17 males and 15 females, while alcohol use was almost uniformly present, with each
group only having 1 individual who did not report alcohol use.
Though the number of alcohol users did not vary between groups, the volume
(frequency by quantity) of alcohol consumed did (F(2,93) = 5.74, p < .01). Here, there
was a significant difference between those with no history of marijuana use and those
who were classified as regular high-frequency marijuana users (p < .05). Specifically,
those who were regular high-frequency users consumed a greater volume of alcohol
than those with no history of marijuana use. No significant differences were observed
between regular low-frequency marijuana users and those with no history of marijuana
use (p > .05), or regular high-frequency marijuana users (p > .05).
In terms of tobacco use, each group had 15 current tobacco smokers and 17
individuals who reported no current tobacco use. No differences were found between
groups in relation to frequency of tobacco use (F(2,93) = .21, p > .10).
Finally, in regard to the distribution of non-clinical panic attacks within the
sample, though matching was not fully achieved,5 no significant differences were found
in regard to the report of non-clinical panic attacks (lifetime) between the 3 groups χ2 (2,
N = 94) = 1.68, p > .10. Among those with no history of marijuana use, 27 individuals
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reported never experiencing a panic attack, while 24 individuals who were regular lowfrequency marijuana users and 26 individuals who were regular high-frequency
marijuana users reported never having experienced a panic attack. Among those who
did report a history of panic, 4 had no history of marijuana use, while 8 were regular lowfrequency users and 5 were regular, high-frequency users.
Zero-Order Correlations among Theoretically-Relevant Variables
Next, the overall pattern of interrelations among the primary predictor and
criterion variables were evaluated. Table 5 shows the inter-correlations, means,
standard deviations, and the observed range (corrected for sampling error) for the
predictor and criterion variables. In terms of the correlation between the grouping
variable and the criterion variables, no significant relation was found between the
trichotomously coded grouping variable and the SUDs difference score (r = .04, p > .10),
DSQ ratings (r = -.01, p > .10), behavioral avoidance ratings (r = .13, p > .10), respiration
rate change (r = -.08, p > .10), or heart rate change (r = -.04, p > .10).
Primary ANOVA Analyses
The primary analyses of challenge responsivity were then formally conducted.
Although the absence of significant zero-order relations between the predictor and
criterion variables places doubt in the utility of completing these analyses, they were run
formally due to the fact that they represent the central test in the investigation as
conceived on an a priori basis. In terms of the change in SUDs ratings from pre to post
challenge, results indicated that none of the marijuana use groups differed in terms of
change in SUDs scores (F(2,93) = .09, p > .10). Furthermore, no group differences were
observed for panic attack symptoms (F(2,93) = .00, p > .10) or avoidance (F(2,92) =
1.03, p > .10) post-challenge. In terms of physiological variables, no group differences
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were observed for either respiration rate (F(2,81) = .25, p > .10) or heart rate (F(2,92) =
1.76, p > .10).6, 7
Post Hoc Analyses
Due to the lack of empirical support for any of the hypotheses, a series of
theoretically-driven post hoc tests were completed. Tables 6 and 7 show the intercorrelations, means, standard deviations, and the observed range (corrected for
sampling error) for the predictor and criterion variables for the second and third post hoc
tests.
Re-evaluating panic responsivity. First, I re-evaluated the primary hypotheses by
re-coding post-challenge panic responsivity. This approach was undertaken to help
evaluate whether lower overall levels of variability decreased the chance of observing
differences across the groups in the original tests. Here, individuals who reported 4 or
more post-challenge panic attack symptoms on the DSQ, at a severity rating of 4 or
greater, were coded as having had a panic attack (Barlow, Brown, & Craske, 1994;
Sanderson et al., 1989). Specifically, based on these criteria, a categorical variable
(panic attack) was created wherein participants were dummy coded as either 0 (no panic
attack during challenge) or 1 (panic attack during challenge).
Descriptive analysis indicated that among those with no history of marijuana use,
21 participants reported experiencing a panic attack post-challenge whereas 11 did not.
A similar although slightly higher, but non-statistically significant, number of participants
reported experiencing a panic attack post-challenge in the other two groups; specifically,
23 in each group reported panic and 9 in each group reporting no panic attack.
A zero-order correlation was then computed between the marijuana use grouping
variable and the new panic attack variable, and results indicated a non-significant
relation (r = .06, p > .10). Although no significant zero-order effect was noted, a
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subsequent chi-square analysis was nonetheless conducted to formally determine if the
3 marijuana use groups differed in terms of the experience of a panic attack postchallenge. Results indicated no significant difference between the groups χ2 (2, N = 96)
= .40, p > .10.
DSM-IV marijuana use criteria. Next, I completed a re-analysis of challenge
responsivity that focused on DSM criteria for use, abuse, and dependence of marijuana
rather than frequency of use of the marijuana. It is possible this type of categorization of
marijuana better tracks degrees of severity than the frequency approach originally
employed. Specifically, among those who reported current marijuana use (both low and
high regular marijuana users combined) diagnoses of marijuana abuse and dependence,
based on criteria presented in Tables 1 and 2, were obtained via the SCID-NP. All those
not meeting criteria for either abuse or dependence were classified as marijuana users.
These three groups were then trichotomously coded (1 = marijuana use, 2 = marijuana
abuse, and 3 = marijuana dependence).
Of the 64 participants who were regular marijuana users, slightly less than half (n
= 30) were categorized as marijuana users (not meeting criteria for either abuse or
dependence). Those meeting criteria for marijuana abuse represented 25% of the
sample (n = 16) and the remaining 18 participants met criteria for marijuana
dependence. Both ANOVA and chi-square analyses were conducted similar to the
analyses described earlier for the main hypotheses (see above), with the dichotomous
post-challenge panic attack variable as an additional criterion variable. In these
analyses, the predictor variable was the newly trichotomously coded diagnosticallydriven marijuana criteria variable.
In terms of the change in SUDs ratings from pre to post challenge, results
indicated that none of the marijuana criteria groups differed in terms of change in SUDs
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scores (F(2,61) = .50, p > .10). Furthermore, no group differences were observed for
avoidance post-challenge (F(2,61) = .29, p > .10). Total panic attack symptoms, on the
other hand, were significantly different between groups (F(2,61) = 3.55, p < .05,  =
.10). Specifically, post hoc analyses indicated that the significant difference was evident
between those abusing and those dependent on marijuana (p < .05), such that those
who were marijuana dependent had greater panic attack symptoms than those who
abused marijuana. No significant differences were found between marijuana users and
those who abused (p > .05), or were dependent on marijuana (p > .05). Though
significant differences were found in terms of total panic attack symptoms, chi-square
analyses indicated no significant difference between groups in relation to the experience
of a panic attack post-challenge χ2 (2, N = 64) = 5.30, p = .07; it is noteworthy, however,
that a trend toward significance was evident. In terms of physiological variables, no
group differences were observed for either respiration rate (F(2,52) = .33, p > .10) or
heart rate (F(2,60) = .56, p > .10).
Marijuana use motives. A final set of post hoc tests were completed that focused
on motivational bases of marijuana use in terms of anxious and fearful responding to
bodily sensations. As outlined in the Background and Significance Section of the present
document, some work suggests coping-oriented marijuana use may play a formative role
in negative affective responding (Mitchell et al., 2007). Given such empirical evidence, I
opted to formally evaluate the utility of coping motives in relation to challenge
responsivity. Here, among those who reported current marijuana use, motives for
marijuana use were examined in relation to the above criterion variables. Separate
multiple regression analyses (Cohen & Cohen, 1983) were conducted for each of the
above criterion variables, with the exception of the dichotomous panic attack variable,
where a logistic regression was used (Cohen & Cohen, 1983). At level 1 of every
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regression analysis, each of the five factors of the MMM: (1) Coping, (2) Expansion, (3)
Conformity, (4) Enhancement, and (5) Social were simultaneously entered into the
equation in addition to frequency of past 30 day marijuana use. This analytic approach
permits an evaluation of the predictive power of each variable in the context of one
another.
In terms of the change in SUDs ratings from pre to post challenge, neither
frequency of past 30 day marijuana use nor any of the marijuana use motives were
significant predictors of change in SUDs scores (all p’s > .10). Regarding avoidance
post-challenge, both coping motives for marijuana use (t = -2.51; β = -.35; sr2 = .10; p <
.05) and frequency of past 30 day marijuana use (t = 2.27; β = .34; sr2 = .08; p < .05)
were significant predictors, such that those who used for greater coping reasons were
less interested in returning for another challenge (greater avoidance), while those who
used greater amounts of marijuana in the past 30 days showed greater interest in
returning for another challenge (less avoidance). Regarding total panic attack symptoms,
coping motives for marijuana use was a unique predictor (t = 2.09; β = .30; sr2 = .07; p <
.05), with all other variables at level 1 being non-significant (all p’s > .10). In terms of the
logistic regression predicting the experience of a panic attack post-challenge, none of
the variables entered were significant predictors (all p’s > .05). For respiration rate, none
of the predictor variables in the regression significantly contributed to the prediction of
change in respiration rate from pre to post-challenge (all p’s > .10). Similar nonsignificance was evident in the prediction of heart rate change (all p’s > .05).8
Discussion
The overarching aim of the present investigation was to examine the role of
different levels of frequency of marijuana use in relation to panic-relevant responding in
the context of a biological challenge paradigm. This investigation is important both
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theoretically and clinically because it serves to help empirically elucidate whether
frequency of marijuana use is a possible vulnerability factor for anxious and fearful
responding to bodily sensations among adult marijuana users.
Main Findings
In contrast to expectation, there was uniformly no empirical evidence that
frequency of marijuana use among the present young adult sample was related to
greater panic responsivity to somatic perturbation from any measurement perspective.
These findings are inconsistent with a past field study that indicated greater frequency of
marijuana use is related to self-reported anxious arousal and lower levels of perceived
health vulnerability (Bonn-Miller et al., 2005). Although there are differences between the
samples studied in the current work and the previous investigation (e.g., percentage of
daily cigarette smokers; Bonn-Miller et al., 2005), the findings are nonetheless in
contrast to such previously reported results. The most parsimonious interpretation of
such results when considered across both investigations is that the previously observed
effect for anxious arousal symptoms and perceived health vulnerability in the Bonn-Miller
and colleagues (2005) study is not evident for panic-relevant symptoms elicited in „real
time.‟ Thus, the tendency to report greater anxiety symptoms and poorer beliefs about
health status generally does not appear to extend to panic symptoms specifically. It
remains unclear whether such differences between the present study and the BonnMiller et al. (2005) investigation are due to methodological reasons (e.g., reporting
biases obtained in real time, distinctions in the dependent variables across the two
studies).
Other past marijuana-anxiety research helps inform the understanding of the
distinctions observed across the Bonn-Miller et al. (2005) and the current investigation.
Here, it is noteworthy that some past work has indicated no main effect for frequency of
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marijuana use in terms of enhanced vulnerability for panic (Buckner et al., in press;
Zvolensky, Bonn-Miller et al., 2006). For example, in one field study, frequency of
marijuana use (at the main effect level) was not related to greater reporting of panicrelevant catastrophic thinking or anxious arousal symptoms among young adult cigarette
smokers (Zvolensky, Bonn-Miller et al., 2006). Similarly, among adolescent marijuana
users, there was no main effect for frequency of marijuana use in regard to self-reported
or physiological responsivity to hyperventilation-induced bodily sensations (Buckner et
al., in press). However, both of these reports did indicate a significant interactive effect
between frequency of marijuana use and anxiety sensitivity (fear of anxiety) for anxious
arousal symptoms and panic-relevant catastrophic thinking. Thus, it may be that
frequency of marijuana use is relevant to understanding panic-relevant symptoms (and
perhaps affective vulnerability more generally) only when coupled with other risk
candidates such as (high levels of) anxiety sensitivity.
At a broad-based level, the present findings, although not in support of the main
hypotheses, help empirically enlighten understanding of marijuana and anxiety
vulnerability associations noted in the literature (e.g., Hollister, 1986; Tunving, 1985). As
noted in the Background and Significance Section, past work has typically employed a
disparate array of assessment devices for anxiety symptoms and problems. Many of
these devices have not been rigorously developed from an evidence-based standpoint
(e.g., Hollister, 1986), often leaving unclear their construct validity as well as reliability
and psychometric properties generally. The current investigation helps clarify those past
studies by using an array of scientifically sound assessment devices from a multimethod
perspective that map onto the experience of anxious and fearful responding. From the
perspective of the current data, there is good reason to question past noted relations
between frequency of marijuana use and anxiety and panic symptoms among young

51

adults (Hollister, 1986). To the extent that there is a lack of an association at the main
effect level between frequency of marijuana use and panic symptoms, theoretical
models that attempt to understand marijuana-panic (and perhaps other anxiety
disorders) co-occurrence will need to be revised (please see Post Hoc test section below
for a further discussion). To even more firmly establish a lack of marijuana frequency
effect for panic-relevant symptoms and problems, it may be advisable for future work to
replicate the current test among different types of marijuana users (e.g., older adults).
Sample characteristics. Although not a primary aim of the study per se, it is
useful to briefly comment on the sample characteristics in regard to the nature of
marijuana use and engagement in other forms of substance use (tobacco and alcohol).
There is a growing recognition that marijuana use does not occur in isolation from other
forms of substance use (Amos, Wiltshire, Bostock, Haw, & McNeill, 2004). For example,
marijuana is the most frequently used illicit drug among cigarette smokers (Smart &
Ogborne, 2000). Yet, the nature of marijuana use in regard to severity or use patterns is
unclear from such prior work.
The current young adult marijuana using sample had slightly less than half not
meeting criteria for either marijuana abuse or dependence, whereas the remaining half
was split relatively equally between the two diagnoses. Of the marijuana using sample,
almost every participant reported current alcohol use, with approximately 90% drinking
alcohol at least 2 to 4 times per month. Regarding alcohol use problems, approximately
75% of the marijuana using sample reported at least moderate alcohol use problems, as
indexed by a score of 8 or greater on the AUDIT (Babor et al., 1992). Daily tobacco use
also was reported by slightly less than half of this sample. These individuals reported
smoking an average of ¾ of a pack of cigarettes daily (a relatively high rate of cigarette
use for young adults). Although the present study should certainly not be considered
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„representative‟ of all young adults in the sense that probability sampling methods were
not employed, they are largely consistent with past observations (Amos et al., 2004).
Moreover, the descriptive characteristics of the sample suggest that not only is cigarette
and alcohol use common among young adult marijuana users, but that it occurs at
relatively severe levels (indexed by daily cigarette use and alcohol use problems).
Together, these data suggest that young adult marijuana users do not simply use
marijuana alone, but rather, engage in multiple forms of substance use simultaneously. It
is likely that future research on substance use and anxiety co-occurrence will need to
develop theoretical models that meaningfully address the relevance of such
polysubstance use in terms of anxiety vulnerability. Regardless of the relevance of such
polysubstance use in terms of anxiety vulnerability per se, it should not be lost that such
high rates of substance use across numerous types of drugs (marijuana, tobacco, and
alcohol) may be related to greater levels of „early‟ medical problems (physical health
disorders) among these individuals later in life (e.g., middle age; Bloom et al., 1987).
In the present investigation, I excluded for a variety of medical disorders that
would be contraindicated from the challenge procedure. However, it would be
interesting, and perhaps clinically useful, to formally evaluate the relative frequency and
severity of medical disorders (physical health conditions) among marijuana users with
and without varying degrees and types of polysubstance use in the future. It is possible
that young adult marijuana users with concurrent polysubstance use may be more apt to
demonstrate the early onset of certain medical conditions (e.g., asthma). It also would be
helpful to empirically inspect the relative degree of use of other forms of substance use
among this population (e.g., opiates) to better gauge the relative extent of „clustering‟ of
substance use to certain classes of drugs. This type of work would broaden the study of
marijuana-anxiety work by tying it to a larger constellation of relevant medical and
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psychological variables of possible theoretical relevance to this type of substance use
behavior.
Post Hoc Tests
A series of post hoc tests were completed to further understand possible
relations between marijuana variables and panic responsivity. As with any post hoc
exploration, caution is needed to interpret these findings. It is perhaps most prudent to
utilize these additional analyses as a „theory-generating‟ tactic in future work focused on
putative marijuana-panic relations as opposed to viewing such information as offering a
definitive conclusion.
Measurement of panic. The first set of post hoc tests were focused on clarifying
whether limited upper-end variability in panic symptom endorsement played a role in the
null effects for the marijuana frequency factors and anxious and fearful responding to
bodily sensations. By re-coding the DSQ panic symptom variables to conform to a panic
attack, there was a pinpointing of those persons who demonstrated the most
responsivity to the challenge. These persons were presumably the „most vulnerable‟ to
panic-related distress. Yet, even when panic responsivity was re-evaluated coding for
the experience of an actual panic attack rather than simply mean DSQ panic symptoms,
no difference was found between marijuana use groups. These findings are consistent
with the continuous DSQ data and therefore do not support a differential effect for
frequency of marijuana use. In total, these results are not consistent with the original
hypothesized relation between frequency of marijuana use and panic responding to a
biological challenge procedure.
DSM-IV marijuana use criteria. I then completed a re-analysis of challenge
responsivity that focused on DSM criteria for use, abuse, and dependence of marijuana
rather than frequency of marijuana use. The logic underlying this re-analysis was that it
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is possible this categorization approach better tracks degrees of severity than the
frequency approach originally employed. Specifically, among those who reported current
marijuana use (both low and high regular marijuana users combined), I examined
diagnoses of marijuana abuse and dependence as well as those not meeting criteria for
either diagnosis (marijuana users). This re-coding indicated that slightly less than half (n
= 30) of the current marijuana users were categorized as marijuana users (not meeting
criteria for either abuse or dependence), whereas 25% (n = 16) were classified as
marijuana abusers, and the remaining (n = 18) 28% were categorized as marijuana
dependent. Thus, there was an excellent range of differences in severity of marijuana
use problems among the present sample.
Partially consistent with prior work among marijuana users, those meeting criteria
for marijuana dependence were found to have greater panic attack symptoms (as
indexed by mean DSQ scores) than those who abused marijuana with no differences
found between those who used (users who did not meet criteria for abuse or
dependence) and those who abused or were dependent on marijuana. This effect was of
a medium size when evaluated using traditional effect size standards (Cohen, 1988).
These differences were not evident when DSQ symptoms were evaluated in terms of the
actual experience of a panic attack post challenge, although a trend was evident. There
were no differences between the groups in regard to SUDS change, behavioral
avoidance, or physiological changes. Despite concern about the attendant risk of Type I
error due to the multiple number of analyses, these results may shed some (limited)
insight into marijuana-panic relations.
One working interpretation of this set of post hoc findings is that, relative to
frequency of marijuana use, a DSM-coding scheme may be a more fruitful strategy for
understanding possible linkages between marijuana and panic psychopathology. In fact,
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at least one other prospective investigation has found marijuana use and dependence,
but not abuse, to be significantly related to an increased risk of panic attacks and panic
disorder (Zvolensky, Lewinsohn et al., in press). Thus, there is some empirical
consistency between the present investigation and that of Zvolensky, Lewinsohn and
colleagues (in press). The lack of an effect for abuse for both investigations is interesting
and may suggest that marijuana abuse is less fruitful for understanding panic
vulnerability relative to use and dependence. The reason for this lack of abuse effect for
panic variables is presently unclear. It may be that different populations of marijuana
users are prone to differential panic risk due to their experience (learning experience
with the drug). For instance, it is possible that there may be greater degrees of risk at
current low (users) and high-levels of problematic (dependence), but less risk for
individuals who are experienced in using the drug but have not progressed to a more
severe level (abusers). This type of account sets the stage for a more fine-grained
marijuana use disorder analysis using measurement that focuses on the types of
experiences individuals have with drug and patterns of use more generally.
Marijuana use motives. A final set of post hoc tests were completed that focused
on motivational bases of marijuana use in terms of anxious and fearful responding to
bodily sensations. This work was informed by a recent investigation that indicated that
only certain motives for marijuana use --- namely, coping-oriented motives --- were
uniquely, concurrently related to self-reported anxious arousal as well as a variety of
other affective vulnerability factors (e.g. anxiety sensitivity; Mitchell et al., 2007). The
theoretical basis for this type of model is that, to the extent that marijuana users believe
that such drug use can be employed as a coping strategy for negative emotional
experiences, those who use more often for negative affect reduction purposes may be
most vulnerable for affect-based psychological vulnerability. Specifically, regardless of
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the actual objective mood dampening effects of using marijuana, regular users of the
drug often believe that such drug use can improve their emotional states (Simons et al.,
1998). In the absence of more adaptive coping skills or the utilization of alternative
coping methods, marijuana users who tend to use for negative affect reduction purposes
may, in fact, be more vulnerable to affective and cognitive distress. This type of
perspective places a unique explanatory role on coping-oriented motivational processes
for marijuana use in terms of affect-based psychological vulnerability factors.
Partially consistent with prediction, coping motives were a significant predictor of
post-challenge avoidance ratings and panic attack symptoms. Greater coping motives
were associated with greater levels of avoidance and more intense panic attack
symptoms. The size of the observed effects for both dependent variables was medium in
effect size using Cohen (1988) standards. It is noteworthy that no other marijuana use
motive showed a similar type of relation. Interestingly, for avoidance ratings, frequency
of past 30 day marijuana use was a significant predictor, such that those who used
greater amounts of marijuana in the past 30 days showed greater interest in returning for
another challenge (less avoidance). This effect is in the opposite direction of that
originally proposed by the current study. There were no other significant effects for any
of the other dependent variables. These data, in conjunction with past work (Mitchell et
al., 2007), collectively suggest that coping motives for marijuana use may be a promising
explanatory candidate for certain aspects of panic vulnerability. Also, there was no
evidence that any other marijuana motives (beyond coping) were positively related to the
studied dependent variables. Such data, considered with the coping motive results,
suggest that very few of the studied motivational variables are systematically or
independently related to anxiety factors. Thus, there is clear evidence of a differential
pattern of associations between types of marijuana use motives and the studied factors
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Although caution should be exercised in over-interpreting these coping-oriented
effects due to, at a minimum, the multiple comparisons completed and underlying post
hoc nature of them, there are a number of possible implications for the present findings.
First, these findings may have important theoretical implications for better understanding
previous research linking marijuana use to affect-based psychological vulnerability
(Brook et al., 2001; Oyefeso, 1991; Zvolensky, Bernstein et al., 2006). One possibility is
that coping motives underlying marijuana use may theoretically influence such drug use
behavior and affective-cognitive processes. For example, coping-related marijuana use
motives may increase the likelihood of experiencing negative emotional states like panic
symptoms, and in turn, may promote more marijuana use. Future work is needed to
follow-up on the present observations in order to clarify the nature of such potential
relations. In this pursuit, it would likely be beneficial to utilize both structural equation
modeling approaches that can model multiple variables concurrently and prospective
assessment methodologies that permit observations across time. Overall, this type of
work will help address whether motives for marijuana use are influenced by emotional
vulnerability processes and/or whether emotional vulnerability shapes marijuana coping
motives.
Study Limitations and Future Directions
Beyond the already noted interpretative caveats of the present study, there are a
number of other points for clarification and targets for future study. First, the present
sample was limited in that it is comprised of a relatively homogenous (e.g., primarily
Caucasian) group of young adults who volunteered to participate in the study for
monetary reward. To rule out potential self-selection bias among persons with these
characteristics and increase the generalizability of these findings, it will be important for
researchers to draw from other populations and utilize recruitment tactics other than
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those used in the present study. For example, recruiting a minority based treatment
seeking population would not only increase upper end variability but also the
generalizability of the findings. Second, the behavioral avoidance findings should be
viewed with caution. It is possible that the person‟s report of their desire to return for a
future challenge may not be fully in line with their actual behavior, such that a participant
may report that they would be willing to return, but may not actually follow through, and
vice versa. It also is possible this measure of avoidance may tap boredom, frustration, or
related factors rather than „pure‟ fear-driven avoidance. Thus, future work should attempt
to solidify this finding through a more rigorous methodology. For example, an experiment
could be designed in which a second challenge is planned minutes following the first
challenge, with which one could determine objectively which participants are willing to
stay for the second administration. Additionally, participants could be called a week
following the challenge to determine if they wish to schedule another appointment.
These approaches allow for a behavioral confirmation of the participant‟s reported
willingness to attend another CO2 administration. Third, the present cross-sectional
correlational design does not permit causal-oriented hypothesis testing. Although an
attempt to strengthen confidence in the observed findings was achieved by matching for
theoretically-relevant factors, causal directions of the observed relations cannot be fully
determined.
Fourth, a persistent challenge to marijuana research is attaining reliable and valid
assessments of the parameters of drug behavior (see Stephens, 1999). In the present
investigation, I followed previous work and examined frequency of marijuana use.
However, it was not possible to attain an assessment of quantity of use due to the wide
degree of variability in marijuana types (i.e., potency) and reliance on recall of
participants to identify an amount used (i.e., memory distortions; Stephens, 1999).
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Although there is no consensus regarding how to unambiguously address this issue,
utilization of biochemical methods would perhaps be a useful tactic. Fifth, given that the
present sample by virtue of selection criteria was psychologically and physically healthy,
the findings are not generalizable to all marijuana users. These selection criteria were
useful and necessary for the purposes of the present investigation to ensure that the
observed marijuana effects were not attributable to correlated psychopathology or
medical disorders. At the same time, to enhance the generalizability of the study results,
future work may benefit by sampling from a more diverse marijuana population. More
specifically, recruiting clinical samples as well as individuals from other racial, socioeconomic, and ethnic backgrounds as well as age groups would possibly introduce a
wider array of motivational patterns, stigma and worry surrounding illegality of use, as
well as representations and severity of disordered use. This more broad-based sampling
approach also may facilitate attaining higher degrees of top-end variability in anxiety as
well as marijuana use variables. Finally, although the present investigation examined a
variety of marijuana factors (e.g., frequency of use, severity of use, motives for use) in
terms of panic responsivity to somatic perturbation, there are other possible factors that
may warrant examination (e.g. marijuana withdrawal symptoms). By continuing to study
possible mechanisms involved in the relation between marijuana and panic, progress
should be made in terms of better understanding the nature of panic-marijuana cooccurrence.
Summary
Overall, the present investigation adds uniquely to the extant empirical literature
on the relation between marijuana use and panic-relevant processes. Although
frequency of marijuana use was not related to enhanced panic responsivity, post hoc
tests suggested that a DSM-oriented categorization or motive-based approach may be
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helpful in understanding marijuana-panic relations. Using this type of basic research to
guide understanding of clinically-relevant processes will continue to be an important task
for translational research efforts focused on marijuana, anxiety, and their disorders.
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Footnotes
1

This study examined the “misuse” of marijuana rather than abuse or dependence. As a

result, I am technically unaware of the precise percentage of those abusing or
dependent on the drug in this specific study.

2

Though researchers still debate about how many “basic” emotions exist, nearly all

models suggest fear/panic represent one overarching (similar) emotional state.

3

These same models posit that emotional factors – both specific and general – may play

key roles in the maintenance and relapse of substance use. Thus, there are bidirectional pathways that are likely operative. However, the present study was
concerned primarily with only one type of relation; specifically, the role of marijuana
predicting future risk for anxious and fearful responding to bodily sensations.

4

Though the inclusion of withdrawal is not currently consistent with DSM-IV criteria for

marijuana dependence, it was included as it is consistent with the definition of marijuana
dependence provided in this manuscript and by Budney and colleagues (2004). It is
likely to be included as a core defining feature of dependence in future DSM iterations.

5

Though matching was not quite achieved, a significant difference was not found

between groups in relation to the experience of non-clinical panic (χ2 (2, N = 94) = 1.68,
p > .10). Given the insignificant difference and that matching was almost achieved, I
chose not to include panic attacks as a covariate in the analyses.
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6

As significant differences were found between groups in relation to volume of alcohol

consumed, all of the main analyses were re-calculated with the inclusion of alcohol use
volume as a covariate. All of the original results were upheld in regard to statistical
significance.

7

Though matching was completed in the sample, the main analyses were recalculated

by gender to assure that no differences were observed between male and female
participants. Analyses indicated similar non-significant results for both female and male
participants, though a trend was evident among males in regard to behavioral
avoidance. Though non-significant, the direction was such that less avoidance was
observed among those with greater marijuana use frequency. No other trends of
statistical significance were noted. Thus, there was no empirical evidence of differential
effects by gender for any of the studied dependent variables for any of the tests
completed.

8

All significant relations that were observed in the original regressions were upheld with

the inclusion of both alcohol (volume – frequency by quantity) and tobacco use
(cigarettes smoked per day) at level 1 in the model.
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Table 1: Criteria for Marijuana Abuse

A. A maladaptive pattern of substance use, leading to clinically significant impairment or
distress, as manifested by one (or more) of the following, occurring within 12-month
period:
1. Recurrent substance use resulting in a failure to fulfill major role obligations at
work, school, or home.
2. Recurrent substance use in situations in which it is physically hazardous.
3. Recurrent substance-related legal problems.
4. Continued substance use despite having persistent or recurrent social or
interpersonal problems caused or exacerbated by the effects of the
substance.
B. The symptoms have never met the criteria for Marijuana Dependence.
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Table 2: Criteria for Marijuana Dependence
A maladaptive pattern of substance use, leading to clinically significant impairment or
distress, as manifested by three (or more) of the following, occurring at any time in the
same 12-month period:
1. Tolerance, as defined by either of the following:
(a) a need for markedly increased amounts of the substance to achieve
intoxication or desired effect
(b) markedly diminished effect with continued use of the same amount of the
substance
2. Withdrawal, as manifested by either of the following 4.
(a) the characteristic withdrawal syndrome for the substance
(b) the same (or closely related) substance is taken to relieve or avoid
withdrawal symptoms
3. The substance is often taken in larger amounts or over a longer period than was
intended.
4. There is a persistent desire or unsuccessful efforts to cut down or control
substance use.
5. A great deal of time is spent in activities necessary to obtain the substance, use
the substance, or recover from its effects.
6. Important social, occupational, or recreational activities are given up or reduced
because of substance use.
7. The substance use is continued despite knowledge of having a persistent or
recurrent physical or psychological problem that is likely to have been caused or
exacerbated by the substance.
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Table 3: Groups
No Marijuana History
1. No lifetime history of marijuana use
2. Matched on current drug use
(alcohol or tobacco use)
3. Excluded for chronic physical
health problems
4. Excluded for current Axis I
psychopathology (including
substance use disorders with the
exception of nicotine dependence)
5. Can have non-clinical panic attacks
(strive for matching)*
6. Matched on gender

Regular, Low-Frequency Use
1. Marijuana use at low rates (no
more than 3 occasions of use per
month for the past 12 months)
2. Matched on current drug use
(alcohol or tobacco use)
3. Excluded for chronic physical
health problems
4. Excluded for current Axis I
psychopathology (including
substance use disorders with the
exception of nicotine and marijuana
abuse or dependence)
5. Can have non-clinical panic attacks
(strive for matching)*
6. Matched on gender

Regular, High-Frequency Use
1. Must have used marijuana at least
5 times per week for the past 12
months.
2. Matched on current drug use
(alcohol or tobacco use)
3. Excluded for chronic physical
health problems
4. Excluded for current Axis I
psychopathology (including
substance use disorders with the
exception of nicotine and marijuana
abuse or dependence)
5. Can have non-clinical panic attacks
(strive for matching)*
6. Matched on gender

82

Table 4: Matching by Subject Number
Gender

No Marijuana Regular, Low-

Male

Regular, High-

History

Frequency Use Frequency Use

2,7,9,14,18,1

6,11,12,15,21,

8,10,17,32,47,5

9,23,27,31,4

22,26,36,41,46

3,59,62,68,69,7

8,60,74,79,8

,56,58,64,75,7

0,71,73,81,82,9

0,84,88,92

6,85,93 (n=17)

5,96 (n=17)

1,3,13,28,33,

5,16,24,29,34,

4,20,25,30,35,3

43,44,49,51,

37,38,42,45,55

9,40,50,54,63,7

52,65,67,77,

,57,61,66,83,9

2,78,86,87,91

89,90 (n=15)

4 (n=15)

(n=15)

1,2,3,7,9,13,

5,6,11,12,15,1

4,8,10,17,20,25

14,18,23,27,

6,21,24,26,29,

,30,32,35,39,40

28,31,33,43,

34,36,37,38,41

,47,50,53,54,59

44,48,49,51,

,42,45,46,55,5

,62,63,68,69,70

52,60,65,67,

6,57,58,61,64,

,71,72,73,78,81

74,77,79,80,

66,75,76,83,85

,82,86,87,91,95

84,88,89,90,

,93,94 (n=31)

(n=31)

(n=17)
Female

Current Alcohol Use
Yes

92 (n=31)
No

19 (n=1)

22 (n=1)

96 (n=1)

Yes

1,2,3,7,9,13,

5,6,11,12,15,1

4,8,10,17,20,25

Current Tobacco Use
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No

14,18,19,23,

6,21,22,24,26,

,30,32,47,53,63

27,28,89,90,

29,41,45,93,94

,68,91,95,96

92 (n=15)

(n=15)

(n=15)

31,33,43,44,

34,36,37,38,42

35,39,40,50,54,

48,49,51,52,

,46,55,56,57,5

59,62,69,70,71,

60,65,67,74,

8,61,64,66,75,

72,73,78,81,82,

77,79,80,84,

76,83,85

86,87 (n=17)

88 (n=17)

(n=17)

23,28,67,89

5,11,24,26,29,

30,54,63,70,86

(n=4)

37,42,94 (n=8)

(n=5)

1,2,3,7,9,13,

6,12,15,16,21,

4,8,10,20,25,32

14,18,27,31,

22,34,36,38,41

,35,39,40,47,50

33,43,44,48,

,45,46,55,56,5

,53,59,62,68,69

49,51,52,60,

7,58,61,64,66,

,71,72,73,78,81

65,74,77,79,

75,76,83,85,93

,82,87,91,95,96

80,84,88,90,

(n=24)

(n=26)

Non-Clinical Panic
Attacks
Yes

No

92 (n=27)
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Table 5: Descriptive Data and Zero-Order (or Bi-variate for Dichotomous Factors) Relations between Primary Predictor
and Criterion Variables
_________________________________________________________________________________________________________
Mean (SD)
Range
1
2
3
4
5
6
_________________________________________________________________________________________________________
Predictor Variable
1. Grouping
33 per group
1-3
.04
-.01
.13
-.08
-.04
Criterion Variables
2. SUDS Change
31.18 (27.21)
-25 - 100
.33** -.19
-.05
.18
3. DSQ
2.89 (1.43)
.19 – 6.19
-.32** .02
.25*
4. Avoidance
65.65 (31.22)
0 – 100
-.23* -.19
5. BPM Change
2.80 (4.45)
-9.10 – 16.65
.18
6. HR Change
10.95 (12.57)
-21.61 – 51.53
__________________________________________________________________________________________________________
Note. N = 84. * p < .05, ** p < .01.Grouping: Trichotomously coded marijuana grouping variable (1 = no history of use, 2
= regular, low-frequency use, 3 = regular, high-frequency use; SUDS Change: Change in Subjective Units of Distress
Scale ratings from pre to post-challenge (Wolpe, 1958); DSQ: Diagnostic Sensations Questionnaire Total Score
(Sanderson, Rapee, Barlow, 1989); Avoidance: Willingness to return for another challenge; BPM Change: Breaths per
minute/Respiration rate change from pre to post-challenge ; HR Change: Heart rate change from pre to post-challenge.
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Table 6: Zero-Order (or Bi-variate for Dichotomous Factors) Relations between Post Hoc Predictor and Criterion
Variables (Among Current Marijuana Users)
_________________________________________________________________________________________________________
1
2
3
4
5
6
7
8
9
10
11
12
13
_________________________________________________________________________________________________________
Predictor Variable
1. Criteria
.65** .58** .38** .07
.39** .35** -.05
.06
-.05
.03
-.10
-.08
2. MJ Use
.38** .38** -.04
.49** .26* -.04
-.03
.21
-.00
-.07
-.26*
3. Coping
.29* .02
.39** .43** .01
.18
-.23
.03
-.05
-.02
4. Expansion
.06
.46** .34** .05
.14
-.07
.14
-.22
.05
5. Conformity
-.15
.30* -.00
.20
-.13
.29* -.05
-.09
6. Enhancement
.52** -.04
-.14
-.01
-.04
-.05
-.24
7. Social
-.05
.01
-.10
.09
-.13
-.09
Criterion Variables
8. SUDS Change
.38** -.16
.30* -.18
.09
9. DSQ
-.44** .71** -.02
.22
10. Avoidance
-.25* -.29* -.28*
11. Panic Attacks
-.18
.16
12. BPM Change
.08
13. HR Change
_________________________________________________________________________________________________________
Note. N = 55. * p < .05, ** p < .01. Criteria: Marijuana use criteria (1 = marijuana use, 2 = marijuana abuse, 3 =
marijuana dependence); MJ Use: Frequency of past 30 day marijuana use; Coping: Marijuana Motives Measure, Coping
Subscale (Simons et al., 1998); Expansion: Marijuana Motives Measure, Expansion Subscale (Simons et al., 1998);
Conformity: Marijuana Motives Measure, Conformity Subscale (Simons et al., 1998); Enhancement: Marijuana Motives
Measure, Enhancement Subscale (Simons et al., 1998); Social: Marijuana Motives Measure, Social Subscale (Simons
et al., 1998); SUDS Change: Change in Subjective Units of Distress Scale ratings from pre to post-challenge (Wolpe,
1958); DSQ: Diagnostic Sensations Questionnaire Total Score (Sanderson, Rapee, Barlow, 1989); Panic Attacks:
Dichotomously coded panic attacks post-challenge (0 = no panic attack, 1 = panic attack); Avoidance: Willingness to
return for another challenge; BPM Change: Breaths per minute/Respiration rate change from pre to post-challenge ; HR
Change: Heart rate change from pre to post-challenge.
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Table 7: Descriptive Data of Post Hoc Predictor and Criterion Variables (Among Current Marijuana Users)
Mean (SD)

Range________________________________________________________________

Predictor Variable
1. Criteria
2. MJ Use
3. Coping
4. Expansion
5. Conformity
6. Enhancement
7. Social

1.81 (.85)
4.48 (2.79)
1.87 (.95)
2.10 (1.05)
1.40 (.53)
3.68 (.99)
2.45 (.96)

1 – 3.00
1 – 8.00
1 – 4.25
1 – 4.80
1 – 3.40
1 – 5.00
1 – 4.20

Criterion Variables
8. SUDS Change
9. DSQ
10. Avoidance
11. Panic Attacks
12. BPM Change
13. HR Change

31.97 (28.68)
2.88 (1.38)
67.14 (30.57)
.72 (.45)
2.57 (4.56)
11.44 (12.71)

-25 – 100
.19 – 6.19
0 – 100
0 – 1.00
-9.10 – 16.65
-21.61 – 46.34

_________________________________________________________________________________________________________
Note. N = 55. Criteria: Marijuana use criteria (1 = marijuana use, 2 = marijuana abuse, 3 = marijuana dependence); MJ
Use: Frequency of past 30 day marijuana use; Coping: Marijuana Motives Measure, Coping Subscale (Simons et al.,
1998); Expansion: Marijuana Motives Measure, Expansion Subscale (Simons et al., 1998); Conformity: Marijuana
Motives Measure, Conformity Subscale (Simons et al., 1998); Enhancement: Marijuana Motives Measure,
Enhancement Subscale (Simons et al., 1998); Social: Marijuana Motives Measure, Social Subscale (Simons et al.,
1998); SUDS Change: Change in Subjective Units of Distress Scale ratings from pre to post-challenge (Wolpe, 1958);
DSQ: Diagnostic Sensations Questionnaire Total Score (Sanderson, Rapee, Barlow, 1989); Panic Attacks:
Dichotomously coded panic attacks post-challenge (0 = no panic attack, 1 = panic attack); Avoidance: Willingness to
return for another challenge; BPM Change: Breaths per minute/Respiration rate change from pre to post-challenge ; HR
Change: Heart rate change from pre to post-challenge.
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Figure 1: Graphical representation of the three theoretically postulated pathways of
marijuana use leading to panic vulnerability
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Figure 2: Schematic diagram of the study procedure
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